Martine Rothblatt, Chairperson and CEO of United Therapeutics Corp (UTHR), sold common shares on the open market 325 times over the past year, totaling about $172.5 million. Her most recent sale occurred on March 11, 2026. These UTHR insider sales rank her 94th among nearly 12,000 individual insiders in our database by total value sold, far exceeding the average of $8.6 million across about six transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 467 | $587.37 | 682,699.0000 | 48,100,000 | 0.07% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 567 | $588.38 | 682,132.0000 | 48,100,000 | 0.08% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 600 | $589.40 | 681,532.0000 | 48,100,000 | 0.09% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 760 | $590.36 | 680,772.0000 | 48,100,000 | 0.11% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 700 | $593.13 | 680,072.0000 | 48,100,000 | 0.10% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $594.11 | 679,872.0000 | 48,100,000 | 0.03% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 380,192.0000 | 48,100,000 | 2.44% | 0.02% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Stock Option | 349192 | $0.00 | 380,192.0000 | 48,100,000 | 47.87% | 0.73% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Stock Options | 349192 | $0.00 | 849,192.0000 | 48,100,000 | 69.84% | 0.73% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Stock Options | 500000 | $0.00 | 349,192.0000 | 48,100,000 | 58.88% | 1.04% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Stock Options | 500000 | $0.00 | 849,192.0000 | 48,100,000 | 143.19% | 1.04% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 886 | $586.14 | 683,166.0000 | 48,100,000 | 0.13% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1161 | $585.00 | 684,052.0000 | 48,100,000 | 0.17% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 980 | $584.04 | 685,213.0000 | 48,100,000 | 0.14% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1391 | $583.08 | 686,193.0000 | 48,100,000 | 0.20% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 805 | $582.19 | 687,584.0000 | 48,100,000 | 0.12% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 503 | $581.10 | 688,389.0000 | 48,100,000 | 0.07% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $580.08 | 688,892.0000 | 48,100,000 | 0.03% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $577.54 | 689,132.0000 | 48,100,000 | 0.02% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 80 | $574.55 | 689,292.0000 | 48,100,000 | 0.01% | 0.00% |
| March 31, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 21,500.0000 | 48,100,000 | 30.65% | 0.02% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $596.11 | 679,872.0000 | 48,100,000 | 0.04% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $595.29 | 680,112.0000 | 48,100,000 | 0.03% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 440 | $594.11 | 680,312.0000 | 48,100,000 | 0.06% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $592.98 | 680,752.0000 | 48,100,000 | 0.04% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 280 | $591.64 | 680,992.0000 | 48,100,000 | 0.04% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 155 | $590.69 | 681,272.0000 | 48,100,000 | 0.02% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 469 | $589.66 | 681,427.0000 | 48,100,000 | 0.07% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 450 | $588.63 | 681,896.0000 | 48,100,000 | 0.07% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 846 | $587.60 | 682,346.0000 | 48,100,000 | 0.12% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 247 | $586.61 | 683,192.0000 | 48,100,000 | 0.04% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $585.11 | 683,439.0000 | 48,100,000 | 0.02% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 31 | $583.56 | 683,599.0000 | 48,100,000 | 0.00% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 602 | $582.75 | 683,630.0000 | 48,100,000 | 0.09% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 610 | $581.72 | 684,232.0000 | 48,100,000 | 0.09% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 190 | $580.54 | 684,842.0000 | 48,100,000 | 0.03% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 280 | $579.35 | 685,032.0000 | 48,100,000 | 0.04% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $578.56 | 685,312.0000 | 48,100,000 | 0.04% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 360 | $577.13 | 685,552.0000 | 48,100,000 | 0.05% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 399 | $576.02 | 685,912.0000 | 48,100,000 | 0.06% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 481 | $574.87 | 686,311.0000 | 48,100,000 | 0.07% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 310 | $573.92 | 686,792.0000 | 48,100,000 | 0.05% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 931 | $572.81 | 687,102.0000 | 48,100,000 | 0.14% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 801 | $571.58 | 688,033.0000 | 48,100,000 | 0.12% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 538 | $570.87 | 688,834.0000 | 48,100,000 | 0.08% | 0.00% |
| April 1, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 50,000.0000 | 48,100,000 | 15.97% | 0.02% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $534.50 | 679,872.0000 | 48,100,000 | 0.02% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 440 | $533.85 | 680,032.0000 | 48,100,000 | 0.06% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 720 | $532.50 | 680,472.0000 | 48,100,000 | 0.11% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 634 | $531.32 | 681,192.0000 | 48,100,000 | 0.09% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 903 | $530.45 | 681,826.0000 | 48,100,000 | 0.13% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 841 | $529.09 | 682,729.0000 | 48,100,000 | 0.12% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 326 | $528.30 | 683,570.0000 | 48,100,000 | 0.05% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 314 | $527.30 | 683,896.0000 | 48,100,000 | 0.05% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 104 | $526.27 | 684,210.0000 | 48,100,000 | 0.02% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1338 | $524.80 | 684,314.0000 | 48,100,000 | 0.20% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1809 | $523.88 | 685,652.0000 | 48,100,000 | 0.26% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1514 | $522.98 | 687,461.0000 | 48,100,000 | 0.22% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 397 | $522.10 | 688,975.0000 | 48,100,000 | 0.06% | 0.00% |
| March 27, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 40,500.0000 | 48,100,000 | 19.00% | 0.02% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $602.72 | 679,872.0000 | 48,100,000 | 0.02% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 98 | $601.57 | 679,992.0000 | 48,100,000 | 0.01% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 182 | $600.52 | 680,090.0000 | 48,100,000 | 0.03% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 280 | $599.48 | 680,272.0000 | 48,100,000 | 0.04% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 201 | $598.52 | 680,552.0000 | 48,100,000 | 0.03% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 319 | $596.87 | 680,753.0000 | 48,100,000 | 0.05% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 320 | $595.80 | 681,072.0000 | 48,100,000 | 0.05% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $594.61 | 681,392.0000 | 48,100,000 | 0.06% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $593.83 | 681,792.0000 | 48,100,000 | 0.04% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $592.19 | 682,032.0000 | 48,100,000 | 0.02% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 602 | $591.24 | 682,152.0000 | 48,100,000 | 0.09% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1068 | $590.32 | 682,754.0000 | 48,100,000 | 0.16% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1734 | $589.18 | 683,822.0000 | 48,100,000 | 0.25% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1790 | $588.33 | 685,556.0000 | 48,100,000 | 0.26% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1346 | $587.34 | 687,346.0000 | 48,100,000 | 0.20% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 354 | $586.07 | 688,692.0000 | 48,100,000 | 0.05% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 86 | $584.80 | 689,046.0000 | 48,100,000 | 0.01% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $583.40 | 689,132.0000 | 48,100,000 | 0.02% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 80 | $581.74 | 689,292.0000 | 48,100,000 | 0.01% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 59,500.0000 | 48,100,000 | 13.77% | 0.02% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 280 | $539.98 | 679,872.0000 | 48,100,000 | 0.04% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 740 | $538.90 | 680,152.0000 | 48,100,000 | 0.11% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1100 | $537.97 | 680,892.0000 | 48,100,000 | 0.16% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1540 | $536.96 | 681,992.0000 | 48,100,000 | 0.23% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2029 | $536.00 | 683,532.0000 | 48,100,000 | 0.30% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1476 | $535.06 | 685,561.0000 | 48,100,000 | 0.21% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 837 | $534.02 | 687,037.0000 | 48,100,000 | 0.12% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 498 | $532.90 | 687,874.0000 | 48,100,000 | 0.07% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 841 | $532.08 | 688,372.0000 | 48,100,000 | 0.12% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 159 | $530.95 | 689,213.0000 | 48,100,000 | 0.02% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 440 | $540.51 | 688,772.0000 | 48,100,000 | 0.06% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $536.97 | 689,252.0000 | 48,100,000 | 0.02% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $538.73 | 689,212.0000 | 48,100,000 | 0.01% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1699 | $541.75 | 687,073.0000 | 48,100,000 | 0.25% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1833 | $542.66 | 685,240.0000 | 48,100,000 | 0.27% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1721 | $543.68 | 683,519.0000 | 48,100,000 | 0.25% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1544 | $544.65 | 681,975.0000 | 48,100,000 | 0.23% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 911 | $545.72 | 681,064.0000 | 48,100,000 | 0.13% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 373 | $546.59 | 680,691.0000 | 48,100,000 | 0.05% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 459 | $547.78 | 680,232.0000 | 48,100,000 | 0.07% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 360 | $548.52 | 679,872.0000 | 48,100,000 | 0.05% | 0.00% |
| March 25, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 69,000.0000 | 48,100,000 | 12.10% | 0.02% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1890 | $533.21 | 681,197.0000 | 48,100,000 | 0.28% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 709 | $534.31 | 680,488.0000 | 48,100,000 | 0.10% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 536 | $535.39 | 679,952.0000 | 48,100,000 | 0.08% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 80 | $536.02 | 679,872.0000 | 48,100,000 | 0.01% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 78,500.0000 | 48,100,000 | 10.80% | 0.02% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 480 | $530.73 | 684,692.0000 | 48,100,000 | 0.07% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 280 | $529.48 | 685,172.0000 | 48,100,000 | 0.04% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $528.02 | 685,452.0000 | 48,100,000 | 0.06% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 680 | $526.94 | 685,852.0000 | 48,100,000 | 0.10% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 480 | $525.93 | 686,532.0000 | 48,100,000 | 0.07% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 256 | $524.62 | 687,012.0000 | 48,100,000 | 0.04% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1605 | $532.24 | 683,087.0000 | 48,100,000 | 0.23% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 737 | $523.93 | 687,268.0000 | 48,100,000 | 0.11% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 527 | $522.89 | 688,005.0000 | 48,100,000 | 0.08% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $521.85 | 688,532.0000 | 48,100,000 | 0.06% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $520.75 | 688,932.0000 | 48,100,000 | 0.02% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 280 | $519.10 | 689,052.0000 | 48,100,000 | 0.04% | 0.00% |
| March 24, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $516.84 | 689,332.0000 | 48,100,000 | 0.01% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $518.39 | 689,132.0000 | 48,100,000 | 0.03% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 88,000.0000 | 48,100,000 | 9.74% | 0.02% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 370 | $536.16 | 679,872.0000 | 48,100,000 | 0.05% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 830 | $535.12 | 680,242.0000 | 48,100,000 | 0.12% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 920 | $533.93 | 681,072.0000 | 48,100,000 | 0.13% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 364 | $533.15 | 681,992.0000 | 48,100,000 | 0.05% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 671 | $531.65 | 682,356.0000 | 48,100,000 | 0.10% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 703 | $530.91 | 683,027.0000 | 48,100,000 | 0.10% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 342 | $529.80 | 683,730.0000 | 48,100,000 | 0.05% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $527.57 | 684,072.0000 | 48,100,000 | 0.02% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 640 | $526.59 | 684,192.0000 | 48,100,000 | 0.09% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $525.43 | 684,832.0000 | 48,100,000 | 0.06% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 647 | $524.15 | 685,232.0000 | 48,100,000 | 0.09% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $522.19 | 685,879.0000 | 48,100,000 | 0.02% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1320 | $521.38 | 686,039.0000 | 48,100,000 | 0.19% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 867 | $520.54 | 687,359.0000 | 48,100,000 | 0.13% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 906 | $519.29 | 688,226.0000 | 48,100,000 | 0.13% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 97,500.0000 | 48,100,000 | 8.88% | 0.02% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 320 | $529.08 | 679,872.0000 | 48,100,000 | 0.05% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 865 | $527.99 | 680,192.0000 | 48,100,000 | 0.13% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 993 | $527.08 | 681,057.0000 | 48,100,000 | 0.15% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 660 | $526.06 | 682,050.0000 | 48,100,000 | 0.10% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1815 | $525.02 | 682,710.0000 | 48,100,000 | 0.27% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2749 | $524.18 | 684,525.0000 | 48,100,000 | 0.40% | 0.01% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1538 | $523.28 | 687,274.0000 | 48,100,000 | 0.22% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 520 | $521.69 | 688,812.0000 | 48,100,000 | 0.08% | 0.00% |
| March 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $520.34 | 689,332.0000 | 48,100,000 | 0.01% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 107,000.0000 | 48,100,000 | 8.15% | 0.02% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $532.90 | 679,872.0000 | 48,100,000 | 0.01% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $531.90 | 679,912.0000 | 48,100,000 | 0.04% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1431 | $531.20 | 680,152.0000 | 48,100,000 | 0.21% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1608 | $530.20 | 681,583.0000 | 48,100,000 | 0.24% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1950 | $529.32 | 683,191.0000 | 48,100,000 | 0.28% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1241 | $528.31 | 685,141.0000 | 48,100,000 | 0.18% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1515 | $527.30 | 686,382.0000 | 48,100,000 | 0.22% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 876 | $526.27 | 687,897.0000 | 48,100,000 | 0.13% | 0.00% |
| March 19, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 599 | $525.08 | 688,773.0000 | 48,100,000 | 0.09% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 419 | $531.71 | 680,072.0000 | 48,100,000 | 0.06% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 116,500.0000 | 48,100,000 | 7.54% | 0.02% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $539.99 | 679,872.0000 | 48,100,000 | 0.02% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $537.66 | 680,032.0000 | 48,100,000 | 0.01% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2739 | $530.94 | 680,491.0000 | 48,100,000 | 0.40% | 0.01% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2558 | $530.09 | 683,230.0000 | 48,100,000 | 0.37% | 0.01% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1064 | $529.05 | 685,788.0000 | 48,100,000 | 0.15% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 732 | $527.93 | 686,852.0000 | 48,100,000 | 0.11% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 871 | $526.95 | 687,584.0000 | 48,100,000 | 0.13% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 546 | $525.99 | 688,455.0000 | 48,100,000 | 0.08% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 331 | $525.08 | 689,001.0000 | 48,100,000 | 0.05% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $522.88 | 689,332.0000 | 48,100,000 | 0.01% | 0.00% |
| March 18, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1840 | $536.26 | 684,532.0000 | 48,100,000 | 0.27% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 727 | $535.05 | 686,372.0000 | 48,100,000 | 0.11% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1076 | $534.14 | 687,099.0000 | 48,100,000 | 0.16% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 667 | $533.16 | 688,175.0000 | 48,100,000 | 0.10% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 397 | $532.24 | 688,842.0000 | 48,100,000 | 0.06% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 133 | $531.21 | 689,239.0000 | 48,100,000 | 0.02% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 126,000.0000 | 48,100,000 | 7.01% | 0.02% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 780 | $540.10 | 679,952.0000 | 48,100,000 | 0.11% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1709 | $539.40 | 680,732.0000 | 48,100,000 | 0.25% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1091 | $538.41 | 682,441.0000 | 48,100,000 | 0.16% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 80 | $540.92 | 679,872.0000 | 48,100,000 | 0.01% | 0.00% |
| March 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $537.32 | 683,532.0000 | 48,100,000 | 0.15% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 135,500.0000 | 48,100,000 | 6.55% | 0.02% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $537.37 | 679,872.0000 | 48,100,000 | 0.02% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 763 | $536.49 | 680,032.0000 | 48,100,000 | 0.11% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1779 | $534.47 | 682,346.0000 | 48,100,000 | 0.26% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1551 | $535.59 | 680,795.0000 | 48,100,000 | 0.23% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2526 | $533.65 | 684,125.0000 | 48,100,000 | 0.37% | 0.01% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1597 | $532.66 | 686,651.0000 | 48,100,000 | 0.23% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 564 | $531.69 | 688,248.0000 | 48,100,000 | 0.08% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $530.73 | 688,812.0000 | 48,100,000 | 0.03% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 360 | $529.16 | 689,012.0000 | 48,100,000 | 0.05% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 689,372.0000 | 48,100,000 | 1.40% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Restricted Stock Units | 37080 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.08% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Restricted Stock Units | 32499 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.07% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | F | Common Stock | 15559 | $536.12 | 679,872.0000 | 48,100,000 | 2.24% | 0.03% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | F | Common Stock | 13637 | $536.12 | 695,431.0000 | 48,100,000 | 1.92% | 0.03% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 37080 | $0.00 | 709,068.0000 | 48,100,000 | 5.52% | 0.08% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 32499 | $0.00 | 671,988.0000 | 48,100,000 | 5.08% | 0.07% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 356 | $543.22 | 639,653.0000 | 48,100,000 | 0.06% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 145,000.0000 | 48,100,000 | 6.15% | 0.02% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 80 | $542.04 | 639,489.0000 | 48,100,000 | 0.01% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 480 | $541.21 | 639,569.0000 | 48,100,000 | 0.07% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 865 | $540.27 | 640,049.0000 | 48,100,000 | 0.13% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1546 | $539.26 | 640,914.0000 | 48,100,000 | 0.24% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2019 | $538.31 | 642,460.0000 | 48,100,000 | 0.31% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2030 | $537.29 | 644,479.0000 | 48,100,000 | 0.31% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1536 | $536.32 | 646,509.0000 | 48,100,000 | 0.24% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 944 | $535.43 | 648,045.0000 | 48,100,000 | 0.15% | 0.00% |
| March 13, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 154,500.0000 | 48,100,000 | 5.79% | 0.02% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 164 | $544.58 | 639,489.0000 | 48,100,000 | 0.03% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 640 | $532.16 | 648,349.0000 | 48,100,000 | 0.10% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 60 | $532.97 | 648,289.0000 | 48,100,000 | 0.01% | 0.00% |
| March 16, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 516 | $534.99 | 647,773.0000 | 48,100,000 | 0.08% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1955 | $536.02 | 645,818.0000 | 48,100,000 | 0.30% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1772 | $536.83 | 644,046.0000 | 48,100,000 | 0.27% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1077 | $537.90 | 642,969.0000 | 48,100,000 | 0.17% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 720 | $538.94 | 642,249.0000 | 48,100,000 | 0.11% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1240 | $539.82 | 641,009.0000 | 48,100,000 | 0.19% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $541.31 | 640,609.0000 | 48,100,000 | 0.06% | 0.00% |
| March 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 600 | $542.33 | 640,009.0000 | 48,100,000 | 0.09% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $531.54 | 648,029.0000 | 48,100,000 | 0.01% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 164,000.0000 | 48,100,000 | 5.48% | 0.02% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 300 | $544.76 | 639,489.0000 | 48,100,000 | 0.05% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1160 | $544.20 | 639,789.0000 | 48,100,000 | 0.18% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $543.04 | 640,949.0000 | 48,100,000 | 0.04% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1178 | $542.13 | 641,189.0000 | 48,100,000 | 0.18% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 942 | $541.04 | 642,367.0000 | 48,100,000 | 0.15% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 840 | $540.07 | 643,309.0000 | 48,100,000 | 0.13% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1095 | $538.92 | 644,149.0000 | 48,100,000 | 0.17% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1106 | $538.01 | 645,244.0000 | 48,100,000 | 0.17% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1215 | $536.95 | 646,350.0000 | 48,100,000 | 0.19% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 824 | $535.82 | 647,565.0000 | 48,100,000 | 0.13% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $533.47 | 648,389.0000 | 48,100,000 | 0.04% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 360 | $532.13 | 648,629.0000 | 48,100,000 | 0.06% | 0.00% |
| March 11, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 173,500.0000 | 48,100,000 | 5.19% | 0.02% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $548.10 | 639,489.0000 | 48,100,000 | 0.02% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $547.14 | 639,609.0000 | 48,100,000 | 0.06% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 480 | $546.21 | 640,009.0000 | 48,100,000 | 0.07% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 936 | $545.05 | 640,489.0000 | 48,100,000 | 0.15% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 824 | $544.04 | 641,425.0000 | 48,100,000 | 0.13% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 560 | $542.88 | 642,249.0000 | 48,100,000 | 0.09% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $541.69 | 642,809.0000 | 48,100,000 | 0.06% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 440 | $540.63 | 643,209.0000 | 48,100,000 | 0.07% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1351 | $539.84 | 643,649.0000 | 48,100,000 | 0.21% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 563 | $539.02 | 645,000.0000 | 48,100,000 | 0.09% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 647 | $537.92 | 645,563.0000 | 48,100,000 | 0.10% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 459 | $535.99 | 646,210.0000 | 48,100,000 | 0.07% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1320 | $535.09 | 646,669.0000 | 48,100,000 | 0.20% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $533.23 | 647,989.0000 | 48,100,000 | 0.01% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $530.49 | 648,069.0000 | 48,100,000 | 0.02% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 800 | $530.03 | 648,189.0000 | 48,100,000 | 0.12% | 0.00% |
| March 10, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $484.27 | 639,489.0000 | 48,100,000 | 0.03% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1001 | $474.12 | 647,463.0000 | 48,100,000 | 0.15% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1118 | $475.36 | 646,345.0000 | 48,100,000 | 0.17% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 880 | $476.37 | 645,465.0000 | 48,100,000 | 0.14% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2194 | $477.53 | 643,271.0000 | 48,100,000 | 0.34% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1212 | $478.32 | 642,059.0000 | 48,100,000 | 0.19% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 582 | $479.63 | 641,477.0000 | 48,100,000 | 0.09% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 938 | $480.47 | 640,539.0000 | 48,100,000 | 0.15% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $481.59 | 640,299.0000 | 48,100,000 | 0.04% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $482.74 | 640,099.0000 | 48,100,000 | 0.03% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 450 | $483.69 | 639,649.0000 | 48,100,000 | 0.07% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 192,500.0000 | 48,100,000 | 4.70% | 0.02% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $500.05 | 648,789.0000 | 48,100,000 | 0.03% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 244 | $509.49 | 648,545.0000 | 48,100,000 | 0.04% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 701 | $510.81 | 647,844.0000 | 48,100,000 | 0.11% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 896 | $511.73 | 646,948.0000 | 48,100,000 | 0.14% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 603 | $512.88 | 646,345.0000 | 48,100,000 | 0.09% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 676 | $513.65 | 645,669.0000 | 48,100,000 | 0.10% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 565 | $514.90 | 645,104.0000 | 48,100,000 | 0.09% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 678 | $515.81 | 644,426.0000 | 48,100,000 | 0.11% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 588 | $516.64 | 643,838.0000 | 48,100,000 | 0.09% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 319 | $517.83 | 643,519.0000 | 48,100,000 | 0.05% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 361 | $518.80 | 643,158.0000 | 48,100,000 | 0.06% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 520 | $519.99 | 642,638.0000 | 48,100,000 | 0.08% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 465 | $520.87 | 642,173.0000 | 48,100,000 | 0.07% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 335 | $522.02 | 641,838.0000 | 48,100,000 | 0.05% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 165 | $523.52 | 641,673.0000 | 48,100,000 | 0.03% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $524.85 | 641,553.0000 | 48,100,000 | 0.02% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 240 | $526.60 | 641,313.0000 | 48,100,000 | 0.04% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1066 | $527.95 | 640,247.0000 | 48,100,000 | 0.17% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 678 | $528.85 | 639,569.0000 | 48,100,000 | 0.11% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 80 | $529.83 | 639,489.0000 | 48,100,000 | 0.01% | 0.00% |
| March 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 183,000.0000 | 48,100,000 | 4.94% | 0.02% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 284 | $471.96 | 648,705.0000 | 48,100,000 | 0.04% | 0.00% |
| March 6, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 241 | $473.23 | 648,464.0000 | 48,100,000 | 0.04% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 279 | $479.89 | 648,710.0000 | 48,100,000 | 0.04% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 481 | $480.56 | 648,229.0000 | 48,100,000 | 0.07% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 510 | $482.05 | 647,719.0000 | 48,100,000 | 0.08% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1293 | $482.93 | 646,426.0000 | 48,100,000 | 0.20% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1728 | $484.05 | 644,698.0000 | 48,100,000 | 0.27% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2625 | $485.00 | 642,073.0000 | 48,100,000 | 0.41% | 0.01% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 798 | $486.20 | 641,275.0000 | 48,100,000 | 0.12% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1199 | $487.02 | 640,076.0000 | 48,100,000 | 0.19% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 587 | $487.98 | 639,489.0000 | 48,100,000 | 0.09% | 0.00% |
| March 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 9500 | $0.00 | 202,000.0000 | 48,100,000 | 4.49% | 0.02% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $497.05 | 639,489.0000 | 48,100,000 | 0.01% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 399 | $486.42 | 648,590.0000 | 48,100,000 | 0.06% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 926 | $487.55 | 647,664.0000 | 48,100,000 | 0.14% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2429 | $488.63 | 645,235.0000 | 48,100,000 | 0.38% | 0.01% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2290 | $489.68 | 642,945.0000 | 48,100,000 | 0.35% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1808 | $490.52 | 641,137.0000 | 48,100,000 | 0.28% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 485 | $491.33 | 640,652.0000 | 48,100,000 | 0.08% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 243 | $492.44 | 640,409.0000 | 48,100,000 | 0.04% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 185 | $493.40 | 640,224.0000 | 48,100,000 | 0.03% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 215 | $494.74 | 640,009.0000 | 48,100,000 | 0.03% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 480 | $495.78 | 639,529.0000 | 48,100,000 | 0.07% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 680 | $494.75 | 647,230.0000 | 48,100,000 | 0.10% | 0.00% |
| March 4, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 9500 | $0.00 | 211,500.0000 | 48,100,000 | 4.30% | 0.02% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 648,989.0000 | 48,100,000 | 1.49% | 0.02% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 283 | $491.68 | 648,706.0000 | 48,100,000 | 0.04% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 340 | $492.53 | 648,366.0000 | 48,100,000 | 0.05% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 456 | $493.71 | 647,910.0000 | 48,100,000 | 0.07% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 221,000.0000 | 48,100,000 | 4.12% | 0.02% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 421 | $507.09 | 639,489.0000 | 48,100,000 | 0.07% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 132 | $506.16 | 639,910.0000 | 48,100,000 | 0.02% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 908 | $505.06 | 640,042.0000 | 48,100,000 | 0.14% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 730 | $503.99 | 640,950.0000 | 48,100,000 | 0.11% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 210 | $503.03 | 641,680.0000 | 48,100,000 | 0.03% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 379 | $501.93 | 641,890.0000 | 48,100,000 | 0.06% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 495 | $500.96 | 642,269.0000 | 48,100,000 | 0.08% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1058 | $499.85 | 642,764.0000 | 48,100,000 | 0.16% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1371 | $498.96 | 643,822.0000 | 48,100,000 | 0.21% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1075 | $498.01 | 645,193.0000 | 48,100,000 | 0.17% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 407 | $496.71 | 646,268.0000 | 48,100,000 | 0.06% | 0.00% |
| March 3, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 555 | $495.87 | 646,675.0000 | 48,100,000 | 0.09% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 311 | $511.05 | 636,810.0000 | 48,100,000 | 0.05% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 239 | $520.05 | 629,826.0000 | 48,100,000 | 0.04% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 420 | $521.07 | 629,406.0000 | 48,100,000 | 0.07% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 300 | $522.14 | 629,106.0000 | 48,100,000 | 0.05% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 379 | $523.19 | 628,727.0000 | 48,100,000 | 0.06% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $524.04 | 628,567.0000 | 48,100,000 | 0.03% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $525.28 | 628,527.0000 | 48,100,000 | 0.01% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 9500 | $0.00 | 230,500.0000 | 48,100,000 | 3.96% | 0.02% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1064 | $515.15 | 632,622.0000 | 48,100,000 | 0.17% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 768 | $515.99 | 631,854.0000 | 48,100,000 | 0.12% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 872 | $517.02 | 630,982.0000 | 48,100,000 | 0.14% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 598 | $517.85 | 630,384.0000 | 48,100,000 | 0.09% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 319 | $518.97 | 630,065.0000 | 48,100,000 | 0.05% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 427 | $509.66 | 637,121.0000 | 48,100,000 | 0.07% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 319 | $508.49 | 637,548.0000 | 48,100,000 | 0.05% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 160 | $507.27 | 637,867.0000 | 48,100,000 | 0.03% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 9500 | $146.03 | 638,027.0000 | 48,100,000 | 1.51% | 0.02% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1360 | $512.83 | 634,728.0000 | 48,100,000 | 0.21% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 722 | $511.95 | 636,088.0000 | 48,100,000 | 0.11% | 0.00% |
| March 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1042 | $514.02 | 633,686.0000 | 48,100,000 | 0.16% | 0.00% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | A | Restricted Stock Units | 37080 | $0.00 | 37,080.0000 | 48,500,000 | 9999.99% | 0.08% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | A | Restricted Stock Units | 32499 | $0.00 | 32,499.0000 | 48,500,000 | 9999.99% | 0.07% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | A | Stock Options | 207720 | $0.00 | 207,720.0000 | 48,500,000 | 9999.99% | 0.43% |
| Jan. 30, 2026 | BETA Technologies, Inc. | $BETA | ROTHBLATT MARTINE A | Not found | A | Class A common stock | 1071 | $0.00 | 1,071.0000 | 220,528,649 | 9999.99% | 0.00% |
| Dec. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2500 | $501.35 | 639,489.0000 | 48,100,000 | 0.39% | 0.01% |
| Dec. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 2000 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.00% |
| Dec. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 2,000.0000 | 48,100,000 | 66.67% | 0.01% |
| Dec. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 6,000.0000 | 48,100,000 | 40.00% | 0.01% |
| Dec. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $507.61 | 639,489.0000 | 48,100,000 | 0.23% | 0.00% |
| Dec. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $505.45 | 640,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 2000 | $120.26 | 641,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Dec. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $510.86 | 639,489.0000 | 48,100,000 | 0.23% | 0.00% |
| Dec. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $509.42 | 640,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $507.24 | 641,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Dec. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $500.52 | 641,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Dec. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3500 | $495.14 | 639,489.0000 | 48,100,000 | 0.54% | 0.01% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $491.77 | 642,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2500 | $492.49 | 640,989.0000 | 48,100,000 | 0.39% | 0.01% |
| Dec. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $494.00 | 639,989.0000 | 48,100,000 | 0.16% | 0.00% |
| Dec. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $497.17 | 639,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 14,000.0000 | 48,100,000 | 22.22% | 0.01% |
| Dec. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 10,000.0000 | 48,100,000 | 28.57% | 0.01% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1976 | $484.30 | 640,013.0000 | 48,100,000 | 0.31% | 0.00% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $483.12 | 641,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 18,000.0000 | 48,100,000 | 18.18% | 0.01% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 22,000.0000 | 48,100,000 | 15.38% | 0.01% |
| Dec. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2900 | $490.98 | 639,489.0000 | 48,100,000 | 0.45% | 0.01% |
| Dec. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1100 | $489.95 | 642,389.0000 | 48,100,000 | 0.17% | 0.00% |
| Dec. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 524 | $485.14 | 639,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1600 | $480.17 | 640,889.0000 | 48,100,000 | 0.25% | 0.00% |
| Dec. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 26,000.0000 | 48,100,000 | 13.33% | 0.01% |
| Dec. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 30,000.0000 | 48,100,000 | 11.76% | 0.01% |
| Dec. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $481.72 | 639,489.0000 | 48,100,000 | 0.16% | 0.00% |
| Dec. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $480.71 | 640,489.0000 | 48,100,000 | 0.06% | 0.00% |
| Dec. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $477.92 | 642,489.0000 | 48,100,000 | 0.16% | 0.00% |
| Dec. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1560 | $479.33 | 639,489.0000 | 48,100,000 | 0.24% | 0.00% |
| Dec. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2440 | $477.63 | 641,049.0000 | 48,100,000 | 0.38% | 0.01% |
| Dec. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 643,489.0000 | 48,100,000 | 0.63% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Common Stock | 5000 | $0.00 | 639,489.0000 | 48,100,000 | 0.78% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $485.78 | 644,989.0000 | 48,100,000 | 0.06% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1092 | $484.55 | 645,389.0000 | 48,100,000 | 0.17% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $482.92 | 646,481.0000 | 48,100,000 | 0.15% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1008 | $482.23 | 647,481.0000 | 48,100,000 | 0.16% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Dec. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $484.31 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Dec. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3000 | $482.94 | 645,489.0000 | 48,100,000 | 0.46% | 0.01% |
| Dec. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 34,000.0000 | 48,100,000 | 10.53% | 0.01% |
| Dec. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 38,000.0000 | 48,100,000 | 9.52% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $488.97 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 42,000.0000 | 48,100,000 | 8.70% | 0.01% |
| Dec. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2595 | $480.60 | 644,489.0000 | 48,100,000 | 0.40% | 0.01% |
| Dec. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1405 | $478.93 | 647,084.0000 | 48,100,000 | 0.22% | 0.00% |
| Dec. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Dec. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1640 | $476.26 | 644,489.0000 | 48,100,000 | 0.25% | 0.00% |
| Dec. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Dec. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $474.10 | 646,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Dec. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 860 | $475.43 | 646,129.0000 | 48,100,000 | 0.13% | 0.00% |
| Dec. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 46,000.0000 | 48,100,000 | 8.00% | 0.01% |
| Dec. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $480.14 | 646,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1731 | $482.95 | 644,489.0000 | 48,100,000 | 0.27% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 54,000.0000 | 48,100,000 | 6.90% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $484.68 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 50,000.0000 | 48,100,000 | 7.41% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1590 | $480.28 | 646,899.0000 | 48,100,000 | 0.25% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1390 | $482.28 | 645,509.0000 | 48,100,000 | 0.21% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 520 | $483.38 | 644,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Dec. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Dec. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $478.64 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Dec. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 769 | $481.72 | 646,220.0000 | 48,100,000 | 0.12% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1366 | $485.24 | 644,989.0000 | 48,100,000 | 0.21% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $487.10 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 800 | $485.71 | 647,689.0000 | 48,100,000 | 0.12% | 0.00% |
| Nov. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1609 | $487.30 | 646,080.0000 | 48,100,000 | 0.25% | 0.00% |
| Nov. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1091 | $488.36 | 644,989.0000 | 48,100,000 | 0.17% | 0.00% |
| Nov. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $490.25 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 62,000.0000 | 48,100,000 | 6.06% | 0.01% |
| Nov. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 58,000.0000 | 48,100,000 | 6.45% | 0.01% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2134 | $484.45 | 646,355.0000 | 48,100,000 | 0.33% | 0.00% |
| Nov. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $472.53 | 644,489.0000 | 48,100,000 | 0.23% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2500 | $469.73 | 645,989.0000 | 48,100,000 | 0.39% | 0.01% |
| Nov. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 66,000.0000 | 48,100,000 | 5.71% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 70,000.0000 | 48,100,000 | 5.41% | 0.01% |
| Nov. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 300 | $481.23 | 644,489.0000 | 48,100,000 | 0.05% | 0.00% |
| Nov. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2164 | $475.67 | 644,789.0000 | 48,100,000 | 0.33% | 0.00% |
| Nov. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1536 | $473.69 | 646,953.0000 | 48,100,000 | 0.24% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2167 | $478.32 | 645,322.0000 | 48,100,000 | 0.33% | 0.00% |
| Nov. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 74,000.0000 | 48,100,000 | 5.13% | 0.01% |
| Nov. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $473.31 | 646,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Nov. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2450 | $475.42 | 644,539.0000 | 48,100,000 | 0.38% | 0.01% |
| Nov. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 50 | $476.07 | 644,489.0000 | 48,100,000 | 0.01% | 0.00% |
| Nov. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 78,000.0000 | 48,100,000 | 4.88% | 0.01% |
| Nov. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 833 | $480.44 | 644,489.0000 | 48,100,000 | 0.13% | 0.00% |
| Nov. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $476.80 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 86,000.0000 | 48,100,000 | 4.44% | 0.01% |
| Nov. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $474.95 | 644,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Nov. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $474.22 | 646,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Nov. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $475.10 | 644,489.0000 | 48,100,000 | 0.23% | 0.00% |
| Nov. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $472.60 | 645,989.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $470.53 | 646,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Nov. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 82,000.0000 | 48,100,000 | 4.65% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 570 | $466.05 | 644,489.0000 | 48,100,000 | 0.09% | 0.00% |
| Nov. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 930 | $464.84 | 645,059.0000 | 48,100,000 | 0.14% | 0.00% |
| Nov. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $461.83 | 645,989.0000 | 48,100,000 | 0.31% | 0.00% |
| Nov. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $460.34 | 647,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 90,000.0000 | 48,100,000 | 4.26% | 0.01% |
| Nov. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 94,000.0000 | 48,100,000 | 4.08% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2500 | $468.32 | 644,489.0000 | 48,100,000 | 0.39% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $466.26 | 646,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 800 | $461.14 | 645,689.0000 | 48,100,000 | 0.12% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 98,000.0000 | 48,100,000 | 3.92% | 0.01% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 650 | $467.39 | 644,489.0000 | 48,100,000 | 0.10% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1290 | $1290.00 | 645,139.0000 | 48,100,000 | 0.20% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1299 | $461.17 | 646,429.0000 | 48,100,000 | 0.20% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 761 | $458.48 | 647,728.0000 | 48,100,000 | 0.12% | 0.00% |
| Nov. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 980 | $458.71 | 646,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $463.24 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 102,000.0000 | 48,100,000 | 3.77% | 0.01% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $455.97 | 647,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 520 | $457.54 | 647,469.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $462.02 | 645,489.0000 | 48,100,000 | 0.03% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 110,000.0000 | 48,100,000 | 3.51% | 0.01% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3500 | $448.27 | 644,989.0000 | 48,100,000 | 0.54% | 0.01% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $449.22 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1097 | $450.64 | 647,392.0000 | 48,100,000 | 0.17% | 0.00% |
| Nov. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1634 | $451.87 | 645,758.0000 | 48,100,000 | 0.25% | 0.00% |
| Nov. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1269 | $452.78 | 644,489.0000 | 48,100,000 | 0.20% | 0.00% |
| Nov. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 106,000.0000 | 48,100,000 | 3.64% | 0.01% |
| Nov. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 114,000.0000 | 48,100,000 | 3.39% | 0.01% |
| Nov. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 118,000.0000 | 48,100,000 | 3.28% | 0.01% |
| Nov. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1180 | $452.21 | 644,489.0000 | 48,100,000 | 0.18% | 0.00% |
| Nov. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 300 | $448.04 | 645,669.0000 | 48,100,000 | 0.05% | 0.00% |
| Nov. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2655 | $448.14 | 645,834.0000 | 48,100,000 | 0.41% | 0.01% |
| Nov. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1345 | $449.44 | 644,489.0000 | 48,100,000 | 0.21% | 0.00% |
| Nov. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2520 | $446.42 | 645,969.0000 | 48,100,000 | 0.39% | 0.01% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $432.53 | 647,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $434.30 | 646,989.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $438.76 | 645,989.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $440.67 | 645,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $442.26 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 126,000.0000 | 48,100,000 | 3.08% | 0.01% |
| Nov. 5, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 122,000.0000 | 48,100,000 | 3.17% | 0.01% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $432.75 | 647,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2300 | $433.93 | 645,689.0000 | 48,100,000 | 0.35% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1200 | $435.07 | 644,489.0000 | 48,100,000 | 0.19% | 0.00% |
| Oct. 31, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2463 | $451.49 | 644,489.0000 | 48,100,000 | 0.38% | 0.01% |
| Oct. 31, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 31, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $447.83 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 130,000.0000 | 48,100,000 | 2.99% | 0.01% |
| Oct. 31, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 134,000.0000 | 48,100,000 | 2.90% | 0.01% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $443.01 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $441.39 | 645,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $438.62 | 645,989.0000 | 48,100,000 | 0.15% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 360 | $434.33 | 646,989.0000 | 48,100,000 | 0.06% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1140 | $433.78 | 647,349.0000 | 48,100,000 | 0.18% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 31, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 537 | $449.84 | 646,952.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $451.29 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1459 | $450.23 | 644,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 541 | $448.43 | 646,448.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $447.14 | 646,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 900 | $439.99 | 644,489.0000 | 48,100,000 | 0.14% | 0.00% |
| Oct. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 138,000.0000 | 48,100,000 | 2.82% | 0.01% |
| Oct. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $435.24 | 645,389.0000 | 48,100,000 | 0.31% | 0.00% |
| Oct. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1100 | $433.31 | 647,389.0000 | 48,100,000 | 0.17% | 0.00% |
| Oct. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 142,000.0000 | 48,100,000 | 2.74% | 0.01% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $411.95 | 646,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1186 | $420.29 | 643,489.0000 | 48,100,000 | 0.18% | 0.00% |
| Oct. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 647,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1991 | $413.58 | 645,498.0000 | 48,100,000 | 0.31% | 0.00% |
| Oct. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 509 | $415.02 | 644,989.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $417.92 | 643,489.0000 | 48,100,000 | 0.23% | 0.00% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 150,000.0000 | 48,100,000 | 2.60% | 0.01% |
| Oct. 28, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 146,000.0000 | 48,100,000 | 2.67% | 0.01% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 647,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1814 | $414.42 | 644,675.0000 | 48,100,000 | 0.28% | 0.00% |
| Oct. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $422.58 | 644,989.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $424.16 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2937 | $423.56 | 645,552.0000 | 48,100,000 | 0.45% | 0.01% |
| Oct. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 563 | $424.64 | 644,989.0000 | 48,100,000 | 0.09% | 0.00% |
| Oct. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $426.40 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 158,000.0000 | 48,100,000 | 2.47% | 0.01% |
| Oct. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 154,000.0000 | 48,100,000 | 2.53% | 0.01% |
| Oct. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2500 | $421.63 | 645,989.0000 | 48,100,000 | 0.39% | 0.01% |
| Oct. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 162,000.0000 | 48,100,000 | 2.41% | 0.01% |
| Oct. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1088 | $425.38 | 647,401.0000 | 48,100,000 | 0.17% | 0.00% |
| Oct. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1412 | $426.18 | 645,989.0000 | 48,100,000 | 0.22% | 0.00% |
| Oct. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $430.35 | 644,989.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $432.20 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 634 | $420.47 | 647,855.0000 | 48,100,000 | 0.10% | 0.00% |
| Oct. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2200 | $422.15 | 645,655.0000 | 48,100,000 | 0.34% | 0.00% |
| Oct. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1166 | $423.07 | 644,489.0000 | 48,100,000 | 0.18% | 0.00% |
| Oct. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 166,000.0000 | 48,100,000 | 2.35% | 0.01% |
| Oct. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2900 | $430.05 | 645,589.0000 | 48,100,000 | 0.45% | 0.01% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1301 | $424.68 | 645,389.0000 | 48,100,000 | 0.20% | 0.00% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 170,000.0000 | 48,100,000 | 2.30% | 0.01% |
| Oct. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 174,000.0000 | 48,100,000 | 2.25% | 0.01% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 500 | $434.22 | 644,489.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 400 | $427.56 | 644,989.0000 | 48,100,000 | 0.06% | 0.00% |
| Oct. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $422.30 | 646,690.0000 | 48,100,000 | 0.03% | 0.00% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1599 | $421.04 | 646,890.0000 | 48,100,000 | 0.25% | 0.00% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1100 | $432.31 | 644,489.0000 | 48,100,000 | 0.17% | 0.00% |
| Oct. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 182,000.0000 | 48,100,000 | 2.15% | 0.01% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 178,000.0000 | 48,100,000 | 2.20% | 0.01% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1654 | $431.51 | 645,335.0000 | 48,100,000 | 0.26% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 846 | $432.86 | 644,489.0000 | 48,100,000 | 0.13% | 0.00% |
| Oct. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $433.42 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $436.47 | 644,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Oct. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $434.80 | 646,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1500 | $430.23 | 646,989.0000 | 48,100,000 | 0.23% | 0.00% |
| Oct. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $441.26 | 644,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 190,000.0000 | 48,100,000 | 2.06% | 0.01% |
| Oct. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 186,000.0000 | 48,100,000 | 2.11% | 0.01% |
| Oct. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 522 | $432.74 | 647,967.0000 | 48,100,000 | 0.08% | 0.00% |
| Oct. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1478 | $434.01 | 646,489.0000 | 48,100,000 | 0.23% | 0.00% |
| Oct. 14, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3000 | $441.40 | 644,489.0000 | 48,100,000 | 0.46% | 0.01% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $437.53 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 194,000.0000 | 48,100,000 | 2.02% | 0.01% |
| Oct. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 198,000.0000 | 48,100,000 | 1.98% | 0.01% |
| Oct. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3000 | $445.28 | 644,489.0000 | 48,100,000 | 0.46% | 0.01% |
| Oct. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $442.96 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $451.24 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $449.58 | 645,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Oct. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $445.25 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $451.87 | 645,489.0000 | 48,100,000 | 0.31% | 0.00% |
| Oct. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $450.31 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 202,000.0000 | 48,100,000 | 1.94% | 0.01% |
| Oct. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 206,000.0000 | 48,100,000 | 1.90% | 0.01% |
| Oct. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $456.52 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 900 | $454.14 | 645,489.0000 | 48,100,000 | 0.14% | 0.00% |
| Oct. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 860 | $448.89 | 646,389.0000 | 48,100,000 | 0.13% | 0.00% |
| Oct. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1240 | $445.29 | 647,249.0000 | 48,100,000 | 0.19% | 0.00% |
| Oct. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $453.28 | 644,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 210,000.0000 | 48,100,000 | 1.87% | 0.01% |
| Oct. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 214,000.0000 | 48,100,000 | 1.83% | 0.01% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3000 | $451.18 | 644,489.0000 | 48,100,000 | 0.46% | 0.01% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $445.24 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1371 | $448.81 | 644,489.0000 | 48,100,000 | 0.21% | 0.00% |
| Oct. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1629 | $445.61 | 645,860.0000 | 48,100,000 | 0.25% | 0.00% |
| Oct. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $443.63 | 647,489.0000 | 48,100,000 | 0.15% | 0.00% |
| Oct. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,100,000 | 0.62% | 0.01% |
| Oct. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1080 | $423.32 | 601,813.0000 | 48,100,000 | 0.18% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 218,000.0000 | 48,100,000 | 1.80% | 0.01% |
| Oct. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 222,000.0000 | 48,100,000 | 1.77% | 0.01% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $436.70 | 598,893.0000 | 48,100,000 | 0.33% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $433.06 | 600,893.0000 | 48,100,000 | 0.33% | 0.00% |
| Oct. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 602,893.0000 | 48,100,000 | 0.67% | 0.01% |
| Oct. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 844 | $426.78 | 598,893.0000 | 48,100,000 | 0.14% | 0.00% |
| Oct. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2076 | $426.02 | 599,737.0000 | 48,100,000 | 0.34% | 0.00% |
| Oct. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 602,893.0000 | 48,100,000 | 0.67% | 0.01% |
| Sept. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1600 | $430.81 | 644,489.0000 | 48,500,000 | 0.25% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1784 | $423.78 | 646,089.0000 | 48,500,000 | 0.28% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 415 | $418.12 | 647,873.0000 | 48,500,000 | 0.06% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 201 | $416.38 | 648,288.0000 | 48,500,000 | 0.03% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 226,000.0000 | 48,500,000 | 1.74% | 0.01% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 230,000.0000 | 48,500,000 | 1.71% | 0.01% |
| Sept. 30, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 4000 | $422.84 | 644,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $426.86 | 647,489.0000 | 48,500,000 | 0.15% | 0.00% |
| Sept. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2300 | $431.90 | 644,489.0000 | 48,500,000 | 0.36% | 0.00% |
| Sept. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 800 | $430.25 | 646,789.0000 | 48,500,000 | 0.12% | 0.00% |
| Sept. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 900 | $429.07 | 647,589.0000 | 48,500,000 | 0.14% | 0.00% |
| Sept. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 234,000.0000 | 48,500,000 | 1.68% | 0.01% |
| Sept. 25, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 238,000.0000 | 48,500,000 | 1.65% | 0.01% |
| Sept. 26, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3000 | $428.68 | 644,489.0000 | 48,500,000 | 0.46% | 0.01% |
| Sept. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $419.79 | 644,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $416.51 | 646,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 684 | $435.84 | 644,489.0000 | 48,500,000 | 0.11% | 0.00% |
| Sept. 23, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 246,000.0000 | 48,500,000 | 1.60% | 0.01% |
| Sept. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 242,000.0000 | 48,500,000 | 1.63% | 0.01% |
| Sept. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3316 | $433.77 | 645,173.0000 | 48,500,000 | 0.51% | 0.01% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $417.89 | 644,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 254,000.0000 | 48,500,000 | 1.55% | 0.01% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 250,000.0000 | 48,500,000 | 1.57% | 0.01% |
| Sept. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 19, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 4000 | $411.08 | 644,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $416.72 | 646,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 258,000.0000 | 48,500,000 | 1.53% | 0.01% |
| Sept. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 262,000.0000 | 48,500,000 | 1.50% | 0.01% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 879 | $406.04 | 644,489.0000 | 48,500,000 | 0.14% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1121 | $405.20 | 645,368.0000 | 48,500,000 | 0.17% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $403.27 | 646,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 865 | $400.90 | 644,489.0000 | 48,500,000 | 0.13% | 0.00% |
| Sept. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3135 | $399.97 | 645,354.0000 | 48,500,000 | 0.48% | 0.01% |
| Sept. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 266,000.0000 | 48,500,000 | 1.48% | 0.01% |
| Sept. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 3000 | $400.59 | 644,489.0000 | 48,500,000 | 0.46% | 0.01% |
| Sept. 16, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $399.28 | 647,489.0000 | 48,500,000 | 0.15% | 0.00% |
| Sept. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 270,000.0000 | 48,500,000 | 1.46% | 0.01% |
| Sept. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 274,000.0000 | 48,500,000 | 1.44% | 0.01% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1460 | $398.19 | 644,489.0000 | 48,500,000 | 0.23% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2540 | $397.71 | 645,949.0000 | 48,500,000 | 0.39% | 0.01% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $404.89 | 644,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $403.91 | 646,489.0000 | 48,500,000 | 0.15% | 0.00% |
| Sept. 12, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1000 | $402.21 | 647,489.0000 | 48,500,000 | 0.15% | 0.00% |
| Sept. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $398.11 | 646,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 282,000.0000 | 48,500,000 | 1.40% | 0.01% |
| Sept. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 4000 | $397.23 | 644,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 4000 | $0.00 | 278,000.0000 | 48,500,000 | 1.42% | 0.01% |
| Sept. 11, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 4000 | $120.26 | 648,489.0000 | 48,500,000 | 0.62% | 0.01% |
| Sept. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2000 | $399.33 | 644,489.0000 | 48,500,000 | 0.31% | 0.00% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Option | 8000 | $0.00 | 286,000.0000 | 48,500,000 | 2.72% | 0.02% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 8000 | $120.26 | 652,489.0000 | 48,500,000 | 1.24% | 0.02% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 6165 | $398.29 | 646,324.0000 | 48,500,000 | 0.94% | 0.01% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1835 | $399.43 | 644,489.0000 | 48,500,000 | 0.28% | 0.00% |
| March 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Common Stock | 229947 | $0.00 | 386,372.0000 | 48,500,000 | 37.31% | 0.47% |
| March 7, 2025 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | G | Common Stock | 229947 | $0.00 | 628,527.0000 | 48,500,000 | 57.69% | 0.47% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 28 | $347.27 | 644,730.0000 | 49,700,000 | 0.00% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 22 | $349.21 | 644,512.0000 | 49,700,000 | 0.00% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 23 | $350.86 | 644,489.0000 | 49,700,000 | 0.00% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 269 | $129.49 | 644,758.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 269 | $0.00 | 0.0000 | 49,700,000 | 100.00% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 196 | $348.20 | 644,534.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 478 | $347.07 | 647,466.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 671 | $349.14 | 644,489.0000 | 49,700,000 | 0.10% | 0.00% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 719 | $345.53 | 647,370.0000 | 49,700,000 | 0.11% | 0.00% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1226 | $346.43 | 646,144.0000 | 49,700,000 | 0.19% | 0.00% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1148 | $347.20 | 644,996.0000 | 49,700,000 | 0.18% | 0.00% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 373 | $348.23 | 644,623.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 98 | $349.88 | 644,525.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 36 | $351.33 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 145 | $345.52 | 647,944.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2306 | $348.19 | 645,160.0000 | 49,700,000 | 0.36% | 0.00% |
| Aug. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 3,869.0000 | 49,700,000 | 48.20% | 0.01% |
| Aug. 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 7,469.0000 | 49,700,000 | 32.52% | 0.01% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 640 | $347.48 | 645,783.0000 | 49,700,000 | 0.10% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 660 | $348.22 | 645,123.0000 | 49,700,000 | 0.10% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 151 | $349.47 | 644,972.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 237 | $350.61 | 644,735.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 173 | $351.81 | 644,562.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 73 | $353.17 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 14,669.0000 | 49,700,000 | 19.71% | 0.01% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 71 | $352.98 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1164 | $352.57 | 644,560.0000 | 49,700,000 | 0.18% | 0.00% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 459 | $351.47 | 645,724.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 390 | $350.10 | 646,183.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 339 | $348.76 | 646,573.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 837 | $347.91 | 646,912.0000 | 49,700,000 | 0.13% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 362 | $343.10 | 646,781.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 946 | $341.76 | 647,143.0000 | 49,700,000 | 0.15% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 340 | $346.34 | 647,749.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 11,069.0000 | 49,700,000 | 24.54% | 0.01% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 138 | $343.64 | 646,643.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 220 | $345.66 | 646,423.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 639 | $348.23 | 645,345.0000 | 49,700,000 | 0.10% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 36 | $329.02 | 648,053.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 79 | $331.53 | 647,974.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 96 | $333.11 | 647,878.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 78 | $334.49 | 647,800.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 118 | $335.84 | 647,682.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 285 | $337.99 | 647,397.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 256 | $339.35 | 647,141.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 152 | $339.93 | 646,989.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 41 | $341.31 | 646,948.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 205 | $343.79 | 646,743.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 127 | $344.70 | 646,616.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 219 | $345.74 | 646,397.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 413 | $346.89 | 645,984.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 808 | $348.86 | 644,537.0000 | 49,700,000 | 0.13% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 48 | $350.33 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 14,669.0000 | 49,700,000 | 19.71% | 0.01% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 660 | $321.92 | 644,646.0000 | 49,700,000 | 0.10% | 0.00% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 157 | $323.06 | 644,489.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 613 | $319.99 | 647,040.0000 | 49,700,000 | 0.09% | 0.00% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1734 | $320.97 | 645,306.0000 | 49,700,000 | 0.27% | 0.00% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 825 | $321.90 | 647,264.0000 | 49,700,000 | 0.13% | 0.00% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1084 | $322.67 | 646,180.0000 | 49,700,000 | 0.17% | 0.00% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1025 | $323.76 | 645,155.0000 | 49,700,000 | 0.16% | 0.00% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 294 | $324.94 | 644,861.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 372 | $325.91 | 644,489.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 434 | $317.73 | 647,655.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2 | $318.49 | 647,653.0000 | 49,700,000 | 0.00% | 0.00% |
| Aug. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 18,269.0000 | 49,700,000 | 16.46% | 0.01% |
| Aug. 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 21,869.0000 | 49,700,000 | 14.13% | 0.01% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 807 | $322.52 | 646,414.0000 | 49,700,000 | 0.12% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 725 | $321.61 | 647,221.0000 | 49,700,000 | 0.11% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 143 | $319.42 | 647,946.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 153 | $329.73 | 645,671.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 514 | $325.87 | 644,959.0000 | 49,700,000 | 0.08% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 322 | $324.76 | 645,473.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1701 | $323.79 | 645,795.0000 | 49,700,000 | 0.26% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 593 | $323.10 | 647,496.0000 | 49,700,000 | 0.09% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 85 | $338.49 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 526 | $337.86 | 644,574.0000 | 49,700,000 | 0.08% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 282 | $336.09 | 645,100.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 122 | $334.72 | 645,382.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 167 | $334.12 | 645,504.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 424 | $327.10 | 644,535.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 158 | $328.17 | 645,824.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 366 | $326.60 | 645,982.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 66 | $323.71 | 646,348.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 25,469.0000 | 49,700,000 | 12.38% | 0.01% |
| Aug. 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 29,069.0000 | 49,700,000 | 11.02% | 0.01% |
| Aug. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 46 | $327.84 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 330 | $331.54 | 644,489.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 226 | $328.74 | 647,863.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 85 | $330.45 | 647,778.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 144 | $332.64 | 647,634.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1370 | $333.77 | 646,264.0000 | 49,700,000 | 0.21% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 834 | $334.95 | 645,430.0000 | 49,700,000 | 0.13% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 858 | $335.73 | 644,572.0000 | 49,700,000 | 0.13% | 0.00% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 83 | $336.86 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 36,269.0000 | 49,700,000 | 9.03% | 0.01% |
| Aug. 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 32,669.0000 | 49,700,000 | 9.93% | 0.01% |
| Aug. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1052 | $329.82 | 647,037.0000 | 49,700,000 | 0.16% | 0.00% |
| Aug. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2218 | $330.63 | 644,819.0000 | 49,700,000 | 0.34% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 365 | $321.87 | 647,724.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1136 | $322.99 | 646,588.0000 | 49,700,000 | 0.18% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1013 | $323.84 | 645,575.0000 | 49,700,000 | 0.16% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 483 | $325.37 | 645,092.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 327 | $326.04 | 644,765.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 276 | $326.88 | 644,489.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 112 | $324.43 | 647,977.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 553 | $325.71 | 647,424.0000 | 49,700,000 | 0.09% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 550 | $327.73 | 646,874.0000 | 49,700,000 | 0.08% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1254 | $328.81 | 645,620.0000 | 49,700,000 | 0.19% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 732 | $329.64 | 644,888.0000 | 49,700,000 | 0.11% | 0.00% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 399 | $330.54 | 644,489.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 43,469.0000 | 49,700,000 | 7.65% | 0.01% |
| Aug. 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 39,869.0000 | 49,700,000 | 8.28% | 0.01% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 76 | $326.21 | 644,489.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 431 | $318.28 | 647,333.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 325 | $316.18 | 647,764.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 648,089.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 178 | $322.44 | 647,911.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 781 | $321.37 | 646,198.0000 | 49,700,000 | 0.12% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 468 | $322.45 | 645,730.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 782 | $324.01 | 644,948.0000 | 49,700,000 | 0.12% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 383 | $325.33 | 644,565.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 583 | $323.86 | 647,328.0000 | 49,700,000 | 0.09% | 0.00% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1121 | $324.87 | 646,207.0000 | 49,700,000 | 0.17% | 0.00% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 841 | $325.71 | 645,366.0000 | 49,700,000 | 0.13% | 0.00% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 483 | $326.96 | 644,883.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 394 | $328.42 | 644,489.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 50,669.0000 | 49,700,000 | 6.63% | 0.01% |
| Aug. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 47,069.0000 | 49,700,000 | 7.10% | 0.01% |
| Aug. 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 354 | $320.10 | 646,979.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 468 | $323.04 | 647,814.0000 | 49,700,000 | 0.07% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 265 | $321.86 | 648,282.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 202 | $319.76 | 648,547.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 202 | $318.68 | 648,749.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 220 | $317.36 | 648,951.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 123 | $316.18 | 649,171.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $312.29 | 649,294.0000 | 49,700,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,334.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 54,269.0000 | 49,700,000 | 6.22% | 0.01% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 57,869.0000 | 49,700,000 | 5.86% | 0.01% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 148 | $329.25 | 645,734.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 513 | $327.76 | 645,882.0000 | 49,700,000 | 0.08% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 384 | $326.51 | 646,395.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1030 | $325.54 | 646,779.0000 | 49,700,000 | 0.16% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 215 | $324.38 | 647,809.0000 | 49,700,000 | 0.03% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 320 | $323.35 | 648,024.0000 | 49,700,000 | 0.05% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 396 | $322.17 | 648,344.0000 | 49,700,000 | 0.06% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 594 | $321.04 | 648,740.0000 | 49,700,000 | 0.09% | 0.00% |
| Aug. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,334.0000 | 49,700,000 | 0.56% | 0.01% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 107 | $329.57 | 645,734.0000 | 49,700,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 527 | $328.74 | 645,841.0000 | 49,700,000 | 0.08% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 243 | $327.60 | 646,368.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 244 | $326.05 | 646,611.0000 | 49,700,000 | 0.04% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 754 | $325.38 | 646,855.0000 | 49,700,000 | 0.12% | 0.00% |
| Aug. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 205 | $323.98 | 647,609.0000 | 49,700,000 | 0.03% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 309 | $313.05 | 649,025.0000 | 49,700,000 | 0.05% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,334.0000 | 49,700,000 | 0.56% | 0.01% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 554 | $314.03 | 648,471.0000 | 49,700,000 | 0.09% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 222 | $314.97 | 648,249.0000 | 49,700,000 | 0.03% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 491 | $317.49 | 647,758.0000 | 49,700,000 | 0.08% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 383 | $318.08 | 647,375.0000 | 49,700,000 | 0.06% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 220 | $319.55 | 647,155.0000 | 49,700,000 | 0.03% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 551 | $320.88 | 646,604.0000 | 49,700,000 | 0.09% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 224 | $321.70 | 646,380.0000 | 49,700,000 | 0.03% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 496 | $322.83 | 645,884.0000 | 49,700,000 | 0.08% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 150 | $323.84 | 645,734.0000 | 49,700,000 | 0.02% | 0.00% |
| July 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 61,469.0000 | 49,700,000 | 5.53% | 0.01% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 65,069.0000 | 49,700,000 | 5.24% | 0.01% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 229 | $332.67 | 649,602.0000 | 49,700,000 | 0.04% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 989 | $333.85 | 648,613.0000 | 49,700,000 | 0.15% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 802 | $334.84 | 647,811.0000 | 49,700,000 | 0.12% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 452 | $335.81 | 647,359.0000 | 49,700,000 | 0.07% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 335 | $337.24 | 647,024.0000 | 49,700,000 | 0.05% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 247 | $337.90 | 646,777.0000 | 49,700,000 | 0.04% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 421 | $339.54 | 646,356.0000 | 49,700,000 | 0.07% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 125 | $340.29 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 98 | $334.48 | 649,733.0000 | 49,700,000 | 0.02% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 515 | $335.73 | 649,218.0000 | 49,700,000 | 0.08% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1432 | $336.81 | 647,786.0000 | 49,700,000 | 0.22% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 822 | $337.75 | 646,964.0000 | 49,700,000 | 0.13% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 453 | $338.98 | 646,511.0000 | 49,700,000 | 0.07% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 138 | $340.03 | 646,373.0000 | 49,700,000 | 0.02% | 0.00% |
| July 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 142 | $341.76 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 68,669.0000 | 49,700,000 | 4.98% | 0.01% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 75,869.0000 | 49,700,000 | 4.53% | 0.01% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 130 | $333.93 | 649,701.0000 | 49,700,000 | 0.02% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 589 | $335.85 | 649,112.0000 | 49,700,000 | 0.09% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 776 | $336.72 | 648,336.0000 | 49,700,000 | 0.12% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 214 | $337.79 | 648,122.0000 | 49,700,000 | 0.03% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 5 | $339.22 | 648,117.0000 | 49,700,000 | 0.00% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 297 | $339.80 | 647,820.0000 | 49,700,000 | 0.05% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 531 | $340.39 | 647,289.0000 | 49,700,000 | 0.08% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 724 | $341.60 | 646,565.0000 | 49,700,000 | 0.11% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 244 | $342.53 | 646,321.0000 | 49,700,000 | 0.04% | 0.00% |
| July 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 90 | $343.79 | 646,231.0000 | 49,700,000 | 0.01% | 0.00% |
| July 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 812 | $336.95 | 649,019.0000 | 49,700,000 | 0.12% | 0.00% |
| July 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 723 | $337.91 | 648,296.0000 | 49,700,000 | 0.11% | 0.00% |
| July 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1115 | $339.29 | 647,181.0000 | 49,700,000 | 0.17% | 0.00% |
| July 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 950 | $339.78 | 646,231.0000 | 49,700,000 | 0.15% | 0.00% |
| July 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 72,269.0000 | 49,700,000 | 4.75% | 0.01% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 83,069.0000 | 49,700,000 | 4.15% | 0.01% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 52 | $331.85 | 649,779.0000 | 49,700,000 | 0.01% | 0.00% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 109 | $332.68 | 649,670.0000 | 49,700,000 | 0.02% | 0.00% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 917 | $334.59 | 648,753.0000 | 49,700,000 | 0.14% | 0.00% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1768 | $335.52 | 646,985.0000 | 49,700,000 | 0.27% | 0.00% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 633 | $336.51 | 646,352.0000 | 49,700,000 | 0.10% | 0.00% |
| July 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 121 | $337.33 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 512 | $331.70 | 649,319.0000 | 49,700,000 | 0.08% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 956 | $332.76 | 648,363.0000 | 49,700,000 | 0.15% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 529 | $333.84 | 647,834.0000 | 49,700,000 | 0.08% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 744 | $334.77 | 647,090.0000 | 49,700,000 | 0.11% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 696 | $335.99 | 646,394.0000 | 49,700,000 | 0.11% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 163 | $337.09 | 646,231.0000 | 49,700,000 | 0.03% | 0.00% |
| July 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 79,469.0000 | 49,700,000 | 4.33% | 0.01% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 205 | $327.32 | 649,626.0000 | 49,700,000 | 0.03% | 0.00% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 749 | $328.75 | 648,877.0000 | 49,700,000 | 0.12% | 0.00% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1502 | $329.61 | 647,375.0000 | 49,700,000 | 0.23% | 0.00% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1017 | $330.43 | 646,358.0000 | 49,700,000 | 0.16% | 0.00% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 127 | $331.15 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 177 | $326.52 | 649,654.0000 | 49,700,000 | 0.03% | 0.00% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 200 | $328.24 | 649,454.0000 | 49,700,000 | 0.03% | 0.00% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 178 | $329.40 | 649,276.0000 | 49,700,000 | 0.03% | 0.00% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 664 | $330.85 | 648,612.0000 | 49,700,000 | 0.10% | 0.00% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1505 | $331.97 | 647,107.0000 | 49,700,000 | 0.23% | 0.00% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 876 | $332.60 | 646,231.0000 | 49,700,000 | 0.14% | 0.00% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 90,269.0000 | 49,700,000 | 3.84% | 0.01% |
| July 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 86,669.0000 | 49,700,000 | 3.99% | 0.01% |
| July 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 309 | $334.75 | 646,231.0000 | 49,700,000 | 0.05% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 97,469.0000 | 49,700,000 | 3.56% | 0.01% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 93,869.0000 | 49,700,000 | 3.69% | 0.01% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 168 | $328.10 | 649,663.0000 | 49,700,000 | 0.03% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 54 | $331.50 | 649,609.0000 | 49,700,000 | 0.01% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 810 | $332.67 | 648,799.0000 | 49,700,000 | 0.12% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1051 | $333.50 | 647,748.0000 | 49,700,000 | 0.16% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 883 | $334.53 | 646,865.0000 | 49,700,000 | 0.14% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 485 | $335.36 | 646,380.0000 | 49,700,000 | 0.07% | 0.00% |
| July 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 149 | $337.34 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 245 | $329.32 | 649,586.0000 | 49,700,000 | 0.04% | 0.00% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 997 | $330.17 | 648,589.0000 | 49,700,000 | 0.15% | 0.00% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 782 | $331.60 | 647,807.0000 | 49,700,000 | 0.12% | 0.00% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 795 | $332.59 | 647,012.0000 | 49,700,000 | 0.12% | 0.00% |
| July 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 472 | $333.52 | 646,540.0000 | 49,700,000 | 0.07% | 0.00% |
| July 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 809 | $328.72 | 646,305.0000 | 49,700,000 | 0.13% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $321.87 | 649,791.0000 | 49,700,000 | 0.01% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 357 | $324.04 | 649,434.0000 | 49,700,000 | 0.05% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1015 | $324.90 | 648,419.0000 | 49,700,000 | 0.16% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 502 | $326.37 | 647,917.0000 | 49,700,000 | 0.08% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 429 | $326.82 | 647,488.0000 | 49,700,000 | 0.07% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1224 | $327.96 | 646,264.0000 | 49,700,000 | 0.19% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 33 | $328.60 | 646,231.0000 | 49,700,000 | 0.01% | 0.00% |
| July 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 627 | $327.14 | 649,204.0000 | 49,700,000 | 0.10% | 0.00% |
| July 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 2090 | $327.97 | 647,114.0000 | 49,700,000 | 0.32% | 0.00% |
| July 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 74 | $329.75 | 646,231.0000 | 49,700,000 | 0.01% | 0.00% |
| July 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 104,669.0000 | 49,700,000 | 3.33% | 0.01% |
| July 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 101,069.0000 | 49,700,000 | 3.44% | 0.01% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 856 | $324.25 | 648,975.0000 | 49,700,000 | 0.13% | 0.00% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 990 | $325.57 | 647,985.0000 | 49,700,000 | 0.15% | 0.00% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1159 | $326.60 | 646,826.0000 | 49,700,000 | 0.18% | 0.00% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 454 | $327.59 | 646,372.0000 | 49,700,000 | 0.07% | 0.00% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 141 | $328.73 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 649,831.0000 | 49,700,000 | 0.56% | 0.01% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 184 | $321.18 | 649,647.0000 | 49,700,000 | 0.03% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 507 | $323.02 | 649,140.0000 | 49,700,000 | 0.08% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1248 | $324.26 | 647,892.0000 | 49,700,000 | 0.19% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 694 | $325.18 | 647,198.0000 | 49,700,000 | 0.11% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 501 | $326.41 | 646,697.0000 | 49,700,000 | 0.08% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 148 | $327.91 | 646,549.0000 | 49,700,000 | 0.02% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 213 | $328.47 | 646,336.0000 | 49,700,000 | 0.03% | 0.00% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 105 | $329.79 | 646,231.0000 | 49,700,000 | 0.02% | 0.00% |
| July 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 111,869.0000 | 49,700,000 | 3.12% | 0.01% |
| July 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 108,269.0000 | 49,700,000 | 3.22% | 0.01% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 115,469.0000 | 49,700,000 | 3.02% | 0.01% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 119,069.0000 | 49,700,000 | 2.93% | 0.01% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 202 | $316.18 | 650,593.0000 | 49,700,000 | 0.03% | 0.00% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 159 | $317.43 | 650,434.0000 | 49,700,000 | 0.02% | 0.00% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 344 | $320.22 | 650,090.0000 | 49,700,000 | 0.05% | 0.00% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 332 | $321.78 | 649,758.0000 | 49,700,000 | 0.05% | 0.00% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 840 | $323.24 | 648,918.0000 | 49,700,000 | 0.13% | 0.00% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1171 | $324.05 | 647,747.0000 | 49,700,000 | 0.18% | 0.00% |
| July 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 552 | $325.26 | 647,195.0000 | 49,700,000 | 0.09% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 595 | $323.33 | 650,200.0000 | 49,700,000 | 0.09% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 733 | $324.06 | 649,467.0000 | 49,700,000 | 0.11% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 435 | $325.27 | 649,032.0000 | 49,700,000 | 0.07% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 247 | $326.79 | 648,785.0000 | 49,700,000 | 0.04% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 459 | $327.86 | 648,326.0000 | 49,700,000 | 0.07% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 865 | $328.98 | 647,461.0000 | 49,700,000 | 0.13% | 0.00% |
| July 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 266 | $329.58 | 647,195.0000 | 49,700,000 | 0.04% | 0.00% |
| July 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1400 | $312.68 | 649,395.0000 | 49,700,000 | 0.22% | 0.00% |
| July 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1936 | $313.50 | 647,459.0000 | 49,700,000 | 0.30% | 0.00% |
| July 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 264 | $314.48 | 647,195.0000 | 49,700,000 | 0.04% | 0.00% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 190 | $313.95 | 650,605.0000 | 49,700,000 | 0.03% | 0.00% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 333 | $315.37 | 650,272.0000 | 49,700,000 | 0.05% | 0.00% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 962 | $316.52 | 649,310.0000 | 49,700,000 | 0.15% | 0.00% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1316 | $317.49 | 647,994.0000 | 49,700,000 | 0.20% | 0.00% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 799 | $318.40 | 647,195.0000 | 49,700,000 | 0.12% | 0.00% |
| July 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 126,269.0000 | 49,700,000 | 2.77% | 0.01% |
| July 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 122,669.0000 | 49,700,000 | 2.85% | 0.01% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 129,869.0000 | 49,700,000 | 2.70% | 0.01% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 457 | $315.58 | 650,338.0000 | 49,700,000 | 0.07% | 0.00% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 551 | $317.30 | 649,787.0000 | 49,700,000 | 0.08% | 0.00% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1088 | $318.27 | 648,699.0000 | 49,700,000 | 0.17% | 0.00% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1310 | $319.26 | 647,389.0000 | 49,700,000 | 0.20% | 0.00% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 194 | $319.88 | 647,195.0000 | 49,700,000 | 0.03% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 287 | $310.13 | 650,508.0000 | 49,700,000 | 0.04% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1703 | $310.75 | 648,805.0000 | 49,700,000 | 0.26% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 270 | $312.22 | 648,535.0000 | 49,700,000 | 0.04% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 153 | $313.52 | 648,382.0000 | 49,700,000 | 0.02% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 851 | $314.85 | 647,531.0000 | 49,700,000 | 0.13% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 231 | $316.42 | 647,300.0000 | 49,700,000 | 0.04% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 4 | $316.92 | 647,296.0000 | 49,700,000 | 0.00% | 0.00% |
| July 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 101 | $318.30 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| July 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 133,469.0000 | 49,700,000 | 2.63% | 0.01% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 254 | $323.26 | 647,607.0000 | 49,700,000 | 0.04% | 0.00% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1002 | $316.41 | 649,793.0000 | 49,700,000 | 0.15% | 0.00% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 484 | $317.49 | 649,309.0000 | 49,700,000 | 0.07% | 0.00% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 744 | $318.74 | 648,565.0000 | 49,700,000 | 0.11% | 0.00% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 655 | $319.80 | 647,910.0000 | 49,700,000 | 0.10% | 0.00% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 715 | $320.99 | 647,195.0000 | 49,700,000 | 0.11% | 0.00% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 127 | $317.09 | 650,668.0000 | 49,700,000 | 0.02% | 0.00% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1431 | $318.94 | 649,237.0000 | 49,700,000 | 0.22% | 0.00% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 743 | $319.61 | 648,494.0000 | 49,700,000 | 0.11% | 0.00% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 372 | $321.31 | 648,122.0000 | 49,700,000 | 0.06% | 0.00% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 261 | $322.27 | 647,861.0000 | 49,700,000 | 0.04% | 0.00% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 412 | $324.58 | 647,195.0000 | 49,700,000 | 0.06% | 0.00% |
| June 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 140,669.0000 | 49,700,000 | 2.50% | 0.01% |
| July 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 137,069.0000 | 49,700,000 | 2.56% | 0.01% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1119 | $318.22 | 647,337.0000 | 49,700,000 | 0.17% | 0.00% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 449 | $316.38 | 650,346.0000 | 49,700,000 | 0.07% | 0.00% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1873 | $318.14 | 648,473.0000 | 49,700,000 | 0.29% | 0.00% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 147,869.0000 | 49,700,000 | 2.38% | 0.01% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 958 | $319.00 | 647,515.0000 | 49,700,000 | 0.15% | 0.00% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 192 | $320.39 | 647,323.0000 | 49,700,000 | 0.03% | 0.00% |
| June 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 128 | $320.88 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 546 | $314.18 | 650,249.0000 | 49,700,000 | 0.08% | 0.00% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 563 | $314.99 | 649,686.0000 | 49,700,000 | 0.09% | 0.00% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 590 | $316.14 | 649,096.0000 | 49,700,000 | 0.09% | 0.00% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 142 | $318.90 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 640 | $317.26 | 648,456.0000 | 49,700,000 | 0.10% | 0.00% |
| June 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 144,269.0000 | 49,700,000 | 2.43% | 0.01% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 96 | $310.71 | 650,699.0000 | 49,700,000 | 0.01% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 341 | $312.75 | 650,358.0000 | 49,700,000 | 0.05% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 591 | $313.91 | 649,767.0000 | 49,700,000 | 0.09% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 756 | $314.98 | 649,011.0000 | 49,700,000 | 0.12% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 122 | $316.57 | 648,889.0000 | 49,700,000 | 0.02% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 935 | $317.52 | 647,954.0000 | 49,700,000 | 0.14% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 637 | $318.54 | 647,317.0000 | 49,700,000 | 0.10% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 122 | $319.33 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| June 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 697 | $318.44 | 650,098.0000 | 49,700,000 | 0.11% | 0.00% |
| June 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1853 | $319.11 | 648,245.0000 | 49,700,000 | 0.29% | 0.00% |
| June 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 886 | $320.02 | 647,359.0000 | 49,700,000 | 0.14% | 0.00% |
| June 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 164 | $321.82 | 647,195.0000 | 49,700,000 | 0.03% | 0.00% |
| June 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 155,069.0000 | 49,700,000 | 2.27% | 0.01% |
| June 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 151,469.0000 | 49,700,000 | 2.32% | 0.01% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1619 | $309.38 | 648,252.0000 | 49,700,000 | 0.25% | 0.00% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 984 | $310.19 | 647,268.0000 | 49,700,000 | 0.15% | 0.00% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 73 | $311.04 | 647,195.0000 | 49,700,000 | 0.01% | 0.00% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 142 | $310.18 | 650,653.0000 | 49,700,000 | 0.02% | 0.00% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 323 | $311.10 | 650,330.0000 | 49,700,000 | 0.05% | 0.00% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 900 | $312.85 | 649,430.0000 | 49,700,000 | 0.14% | 0.00% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1137 | $314.59 | 648,293.0000 | 49,700,000 | 0.18% | 0.00% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1048 | $315.35 | 647,245.0000 | 49,700,000 | 0.16% | 0.00% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 50 | $315.99 | 647,195.0000 | 49,700,000 | 0.01% | 0.00% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 162,269.0000 | 49,700,000 | 2.17% | 0.01% |
| June 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 158,669.0000 | 49,700,000 | 2.22% | 0.01% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 257 | $304.93 | 650,538.0000 | 49,700,000 | 0.04% | 0.00% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 293 | $306.66 | 650,245.0000 | 49,700,000 | 0.05% | 0.00% |
| June 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 374 | $308.21 | 649,871.0000 | 49,700,000 | 0.06% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 297 | $302.74 | 649,625.0000 | 49,700,000 | 0.05% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 797 | $304.21 | 648,828.0000 | 49,700,000 | 0.12% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1318 | $305.48 | 647,510.0000 | 49,700,000 | 0.20% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 315 | $306.23 | 647,195.0000 | 49,700,000 | 0.05% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 165,869.0000 | 49,700,000 | 2.12% | 0.01% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 169,469.0000 | 49,700,000 | 2.08% | 0.01% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 249 | $286.37 | 650,546.0000 | 49,700,000 | 0.04% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 236 | $287.44 | 650,310.0000 | 49,700,000 | 0.04% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 486 | $289.93 | 649,824.0000 | 49,700,000 | 0.07% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 246 | $291.09 | 649,578.0000 | 49,700,000 | 0.04% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 81 | $292.17 | 649,497.0000 | 49,700,000 | 0.01% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 324 | $294.11 | 649,173.0000 | 49,700,000 | 0.05% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 643 | $295.41 | 648,530.0000 | 49,700,000 | 0.10% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 804 | $296.33 | 647,726.0000 | 49,700,000 | 0.12% | 0.00% |
| June 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 531 | $297.20 | 647,195.0000 | 49,700,000 | 0.08% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 151 | $297.47 | 650,644.0000 | 49,700,000 | 0.02% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 161 | $298.58 | 650,483.0000 | 49,700,000 | 0.02% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 327 | $300.09 | 650,156.0000 | 49,700,000 | 0.05% | 0.00% |
| June 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 234 | $301.39 | 649,922.0000 | 49,700,000 | 0.04% | 0.00% |
| June 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1273 | $286.50 | 649,522.0000 | 49,700,000 | 0.20% | 0.00% |
| June 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1772 | $287.40 | 647,750.0000 | 49,700,000 | 0.27% | 0.00% |
| June 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 555 | $288.28 | 647,195.0000 | 49,700,000 | 0.09% | 0.00% |
| June 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 173,069.0000 | 49,700,000 | 2.04% | 0.01% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 146 | $279.75 | 650,649.0000 | 49,700,000 | 0.02% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 125 | $280.73 | 650,524.0000 | 49,700,000 | 0.02% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 230 | $281.66 | 650,294.0000 | 49,700,000 | 0.04% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 393 | $283.95 | 649,901.0000 | 49,700,000 | 0.06% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 430 | $284.75 | 649,471.0000 | 49,700,000 | 0.07% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 791 | $285.84 | 648,680.0000 | 49,700,000 | 0.12% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 367 | $286.86 | 648,313.0000 | 49,700,000 | 0.06% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1118 | $287.64 | 647,195.0000 | 49,700,000 | 0.17% | 0.00% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 176,669.0000 | 49,700,000 | 2.00% | 0.01% |
| June 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1462 | $281.91 | 647,195.0000 | 49,700,000 | 0.23% | 0.00% |
| June 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 180,269.0000 | 49,700,000 | 1.96% | 0.01% |
| June 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 183,869.0000 | 49,700,000 | 1.92% | 0.01% |
| June 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 267 | $274.15 | 650,528.0000 | 49,700,000 | 0.04% | 0.00% |
| June 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1534 | $275.13 | 648,994.0000 | 49,700,000 | 0.24% | 0.00% |
| June 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1250 | $276.15 | 647,744.0000 | 49,700,000 | 0.19% | 0.00% |
| June 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 549 | $277.09 | 647,195.0000 | 49,700,000 | 0.08% | 0.00% |
| June 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 25 | $278.70 | 650,770.0000 | 49,700,000 | 0.00% | 0.00% |
| June 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 676 | $279.88 | 650,094.0000 | 49,700,000 | 0.10% | 0.00% |
| June 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1437 | $281.12 | 648,657.0000 | 49,700,000 | 0.22% | 0.00% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 750 | $275.71 | 647,195.0000 | 49,700,000 | 0.12% | 0.00% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 770 | $275.33 | 650,025.0000 | 49,700,000 | 0.12% | 0.00% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 802 | $276.36 | 649,223.0000 | 49,700,000 | 0.12% | 0.00% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1067 | $277.38 | 648,156.0000 | 49,700,000 | 0.16% | 0.00% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 600 | $278.61 | 647,556.0000 | 49,700,000 | 0.09% | 0.00% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 361 | $279.45 | 647,195.0000 | 49,700,000 | 0.06% | 0.00% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 446 | $270.88 | 650,349.0000 | 49,700,000 | 0.07% | 0.00% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 608 | $272.74 | 649,741.0000 | 49,700,000 | 0.09% | 0.00% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 491 | $273.46 | 649,250.0000 | 49,700,000 | 0.08% | 0.00% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 187,469.0000 | 49,700,000 | 1.88% | 0.01% |
| June 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1305 | $274.72 | 647,945.0000 | 49,700,000 | 0.20% | 0.00% |
| June 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 191,069.0000 | 49,700,000 | 1.85% | 0.01% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 459 | $278.48 | 647,359.0000 | 49,700,000 | 0.07% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 120 | $273.08 | 650,675.0000 | 49,700,000 | 0.02% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 40 | $274.08 | 650,635.0000 | 49,700,000 | 0.01% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 361 | $275.99 | 650,274.0000 | 49,700,000 | 0.06% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 960 | $277.09 | 649,314.0000 | 49,700,000 | 0.15% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1497 | $278.01 | 647,817.0000 | 49,700,000 | 0.23% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 622 | $278.85 | 647,195.0000 | 49,700,000 | 0.10% | 0.00% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 168 | $274.72 | 650,627.0000 | 49,700,000 | 0.03% | 0.00% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1220 | $276.33 | 649,407.0000 | 49,700,000 | 0.19% | 0.00% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1589 | $277.04 | 647,818.0000 | 49,700,000 | 0.24% | 0.00% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 164 | $279.36 | 647,195.0000 | 49,700,000 | 0.03% | 0.00% |
| June 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 198,269.0000 | 49,700,000 | 1.78% | 0.01% |
| June 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 194,669.0000 | 49,700,000 | 1.82% | 0.01% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 201,869.0000 | 49,700,000 | 1.75% | 0.01% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 296 | $274.68 | 650,499.0000 | 49,700,000 | 0.05% | 0.00% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1177 | $275.70 | 649,322.0000 | 49,700,000 | 0.18% | 0.00% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1227 | $276.61 | 648,095.0000 | 49,700,000 | 0.19% | 0.00% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 322 | $277.74 | 647,773.0000 | 49,700,000 | 0.05% | 0.00% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 312 | $278.79 | 647,461.0000 | 49,700,000 | 0.05% | 0.00% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 266 | $279.46 | 647,195.0000 | 49,700,000 | 0.04% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1375 | $272.09 | 649,420.0000 | 49,700,000 | 0.21% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1081 | $272.91 | 648,339.0000 | 49,700,000 | 0.17% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 439 | $273.95 | 647,900.0000 | 49,700,000 | 0.07% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 343 | $275.09 | 647,557.0000 | 49,700,000 | 0.05% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 123 | $276.48 | 647,434.0000 | 49,700,000 | 0.02% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 117 | $277.42 | 647,317.0000 | 49,700,000 | 0.02% | 0.00% |
| June 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 122 | $278.07 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| June 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 205,469.0000 | 49,700,000 | 1.72% | 0.01% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 212,669.0000 | 49,700,000 | 1.66% | 0.01% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 109 | $267.15 | 650,686.0000 | 49,700,000 | 0.02% | 0.00% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 549 | $268.99 | 650,137.0000 | 49,700,000 | 0.08% | 0.00% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1514 | $269.91 | 648,623.0000 | 49,700,000 | 0.23% | 0.00% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1291 | $270.87 | 647,332.0000 | 49,700,000 | 0.20% | 0.00% |
| May 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 137 | $271.69 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 175 | $269.35 | 650,620.0000 | 49,700,000 | 0.03% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 928 | $270.75 | 649,692.0000 | 49,700,000 | 0.14% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1093 | $271.81 | 648,599.0000 | 49,700,000 | 0.17% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 1054 | $274.63 | 647,545.0000 | 49,700,000 | 0.16% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 141 | $273.45 | 647,404.0000 | 49,700,000 | 0.02% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | S | Common Stock | 209 | $274.86 | 647,195.0000 | 49,700,000 | 0.03% | 0.00% |
| May 31, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Chairperson & CEO | M | Stock Options | 3600 | $0.00 | 209,069.0000 | 49,700,000 | 1.69% | 0.01% |
| May 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 296 | $267.77 | 650,499.0000 | 49,700,000 | 0.05% | 0.00% |
| May 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1776 | $268.78 | 648,723.0000 | 49,700,000 | 0.27% | 0.00% |
| May 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1442 | $269.54 | 647,281.0000 | 49,700,000 | 0.22% | 0.00% |
| May 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 86 | $271.26 | 647,195.0000 | 49,700,000 | 0.01% | 0.00% |
| May 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 501 | $265.22 | 650,294.0000 | 49,700,000 | 0.08% | 0.00% |
| May 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 805 | $265.97 | 649,489.0000 | 49,700,000 | 0.12% | 0.00% |
| May 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1212 | $267.59 | 648,277.0000 | 49,700,000 | 0.19% | 0.00% |
| May 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1082 | $268.35 | 647,195.0000 | 49,700,000 | 0.17% | 0.00% |
| May 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 219,869.0000 | 49,700,000 | 1.61% | 0.01% |
| May 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 216,269.0000 | 49,700,000 | 1.64% | 0.01% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 223,469.0000 | 49,700,000 | 1.59% | 0.01% |
| May 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 645 | $274.50 | 650,150.0000 | 49,700,000 | 0.10% | 0.00% |
| May 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1347 | $275.54 | 648,803.0000 | 49,700,000 | 0.21% | 0.00% |
| May 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1247 | $276.36 | 647,556.0000 | 49,700,000 | 0.19% | 0.00% |
| May 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 361 | $277.03 | 647,195.0000 | 49,700,000 | 0.06% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 234 | $270.92 | 650,561.0000 | 49,700,000 | 0.04% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1959 | $272.01 | 648,602.0000 | 49,700,000 | 0.30% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1014 | $272.85 | 647,588.0000 | 49,700,000 | 0.16% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 146 | $273.94 | 647,442.0000 | 49,700,000 | 0.02% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 125 | $275.28 | 647,317.0000 | 49,700,000 | 0.02% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 88 | $276.63 | 647,229.0000 | 49,700,000 | 0.01% | 0.00% |
| May 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 34 | $277.27 | 647,195.0000 | 49,700,000 | 0.01% | 0.00% |
| May 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 227,069.0000 | 49,700,000 | 1.56% | 0.01% |
| May 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1588 | $277.85 | 647,195.0000 | 49,700,000 | 0.24% | 0.00% |
| May 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 212 | $275.23 | 650,583.0000 | 49,700,000 | 0.03% | 0.00% |
| May 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 510 | $276.17 | 650,073.0000 | 49,700,000 | 0.08% | 0.00% |
| May 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1290 | $277.13 | 648,783.0000 | 49,700,000 | 0.20% | 0.00% |
| May 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 230,669.0000 | 49,700,000 | 1.54% | 0.01% |
| May 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 902 | $274.70 | 649,893.0000 | 49,700,000 | 0.14% | 0.00% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1063 | $273.24 | 649,732.0000 | 49,700,000 | 0.16% | 0.00% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 2399 | $274.16 | 647,333.0000 | 49,700,000 | 0.37% | 0.00% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 138 | $274.93 | 647,195.0000 | 49,700,000 | 0.02% | 0.00% |
| May 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1149 | $275.80 | 648,744.0000 | 49,700,000 | 0.18% | 0.00% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 983 | $276.53 | 647,761.0000 | 49,700,000 | 0.15% | 0.00% |
| May 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 565 | $277.68 | 647,196.0000 | 49,700,000 | 0.09% | 0.00% |
| May 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1 | $278.29 | 647,195.0000 | 49,700,000 | 0.00% | 0.00% |
| May 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 237,869.0000 | 49,700,000 | 1.49% | 0.01% |
| May 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 234,269.0000 | 49,700,000 | 1.51% | 0.01% |
| May 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 533 | $274.27 | 647,195.0000 | 49,700,000 | 0.08% | 0.00% |
| May 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 245,069.0000 | 49,700,000 | 1.45% | 0.01% |
| May 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 383 | $272.69 | 649,838.0000 | 49,700,000 | 0.06% | 0.00% |
| May 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 477 | $271.30 | 650,318.0000 | 49,700,000 | 0.07% | 0.00% |
| May 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 2110 | $273.65 | 647,728.0000 | 49,700,000 | 0.32% | 0.00% |
| May 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1455 | $271.97 | 648,863.0000 | 49,700,000 | 0.22% | 0.00% |
| May 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Stock Options | 3600 | $0.00 | 241,469.0000 | 49,700,000 | 1.47% | 0.01% |
| May 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 1668 | $273.03 | 647,195.0000 | 49,700,000 | 0.26% | 0.00% |
| May 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | M | Common Stock | 3600 | $129.49 | 650,795.0000 | 49,700,000 | 0.56% | 0.01% |
| May 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | Not found | S | Common Stock | 574 | $271.30 | 650,221.0000 | 49,700,000 | 0.09% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 304 | $270.45 | 3,426.0000 | 49,700,000 | 8.15% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 248,669.0000 | 49,700,000 | 1.43% | 0.01% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 252,269.0000 | 49,700,000 | 1.41% | 0.01% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 187 | $274.79 | 130.0000 | 49,700,000 | 58.99% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 853 | $273.89 | 317.0000 | 49,700,000 | 72.91% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1921 | $272.97 | 1,170.0000 | 49,700,000 | 62.15% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 335 | $271.49 | 3,091.0000 | 49,700,000 | 9.78% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 379 | $269.32 | 130.0000 | 49,700,000 | 74.46% | 0.00% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1353 | $268.41 | 509.0000 | 49,700,000 | 72.66% | 0.00% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1083 | $267.53 | 1,862.0000 | 49,700,000 | 36.77% | 0.00% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 754 | $266.34 | 2,945.0000 | 49,700,000 | 20.38% | 0.00% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 31 | $264.35 | 3,699.0000 | 49,700,000 | 0.83% | 0.00% |
| May 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1749 | $264.44 | 1,981.0000 | 49,700,000 | 46.89% | 0.00% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 894 | $265.40 | 1,087.0000 | 49,700,000 | 45.13% | 0.00% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 619 | $267.02 | 468.0000 | 49,700,000 | 56.95% | 0.00% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 224 | $268.10 | 244.0000 | 49,700,000 | 47.86% | 0.00% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 114 | $269.13 | 130.0000 | 49,700,000 | 46.72% | 0.00% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1672 | $264.39 | 2,058.0000 | 49,700,000 | 44.83% | 0.00% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 850 | $265.40 | 1,208.0000 | 49,700,000 | 41.30% | 0.00% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 647 | $266.56 | 561.0000 | 49,700,000 | 53.56% | 0.00% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 251 | $267.84 | 310.0000 | 49,700,000 | 44.74% | 0.00% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 180 | $268.89 | 130.0000 | 49,700,000 | 58.06% | 0.00% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 259,469.0000 | 49,700,000 | 1.37% | 0.01% |
| May 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 255,869.0000 | 49,700,000 | 1.39% | 0.01% |
| May 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 682 | $265.82 | 130.0000 | 49,700,000 | 83.99% | 0.00% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 263,069.0000 | 49,700,000 | 1.35% | 0.01% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 266,669.0000 | 49,700,000 | 1.33% | 0.01% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 839 | $261.33 | 2,891.0000 | 49,700,000 | 22.49% | 0.00% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1430 | $262.38 | 1,461.0000 | 49,700,000 | 49.46% | 0.00% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 223 | $263.10 | 1,238.0000 | 49,700,000 | 15.26% | 0.00% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 713 | $264.75 | 525.0000 | 49,700,000 | 57.59% | 0.00% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 113 | $266.10 | 412.0000 | 49,700,000 | 21.52% | 0.00% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 253 | $266.58 | 159.0000 | 49,700,000 | 61.41% | 0.00% |
| May 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 29 | $268.30 | 130.0000 | 49,700,000 | 18.24% | 0.00% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 247 | $261.83 | 3,483.0000 | 49,700,000 | 6.62% | 0.00% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1006 | $262.79 | 2,477.0000 | 49,700,000 | 28.88% | 0.00% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 562 | $263.98 | 1,915.0000 | 49,700,000 | 22.69% | 0.00% |
| May 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1103 | $265.21 | 812.0000 | 49,700,000 | 57.60% | 0.00% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 811 | $266.13 | 130.0000 | 49,700,000 | 86.18% | 0.00% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 617 | $261.63 | 3,113.0000 | 49,700,000 | 16.54% | 0.00% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 930 | $262.73 | 2,183.0000 | 49,700,000 | 29.87% | 0.00% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 927 | $263.97 | 1,256.0000 | 49,700,000 | 42.46% | 0.00% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 315 | $264.91 | 941.0000 | 49,700,000 | 25.08% | 0.00% |
| May 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 270,269.0000 | 49,700,000 | 1.31% | 0.01% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 496 | $257.70 | 3,014.0000 | 49,700,000 | 14.13% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 115 | $257.30 | 3,615.0000 | 49,700,000 | 3.08% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 699 | $258.24 | 2,916.0000 | 49,700,000 | 19.34% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 799 | $259.11 | 2,117.0000 | 49,700,000 | 27.40% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 574 | $260.43 | 1,543.0000 | 49,700,000 | 27.11% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1191 | $261.51 | 352.0000 | 49,700,000 | 77.19% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 222 | $262.33 | 130.0000 | 49,700,000 | 63.07% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 220 | $256.35 | 3,510.0000 | 49,700,000 | 5.90% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 599 | $259.15 | 2,415.0000 | 49,700,000 | 19.87% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1982 | $260.28 | 433.0000 | 49,700,000 | 82.07% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 157 | $261.51 | 276.0000 | 49,700,000 | 36.26% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4 | $261.94 | 272.0000 | 49,700,000 | 1.45% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 142 | $264.14 | 130.0000 | 49,700,000 | 52.21% | 0.00% |
| May 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 277,469.0000 | 49,700,000 | 1.28% | 0.01% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 273,869.0000 | 49,700,000 | 1.30% | 0.01% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 284,669.0000 | 49,700,000 | 1.25% | 0.01% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 238 | $238.33 | 3,492.0000 | 49,700,000 | 6.38% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 103 | $242.79 | 3,389.0000 | 49,700,000 | 2.95% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 246 | $243.44 | 3,143.0000 | 49,700,000 | 7.26% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 186 | $245.26 | 2,957.0000 | 49,700,000 | 5.92% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 231 | $247.36 | 2,726.0000 | 49,700,000 | 7.81% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 291 | $248.78 | 2,435.0000 | 49,700,000 | 10.67% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 208 | $250.33 | 2,227.0000 | 49,700,000 | 8.54% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 501 | $251.54 | 1,726.0000 | 49,700,000 | 22.50% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 307 | $252.91 | 1,419.0000 | 49,700,000 | 17.79% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 610 | $254.07 | 809.0000 | 49,700,000 | 42.99% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 558 | $254.99 | 251.0000 | 49,700,000 | 68.97% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 95 | $256.13 | 156.0000 | 49,700,000 | 37.85% | 0.00% |
| May 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 26 | $257.55 | 130.0000 | 49,700,000 | 16.67% | 0.00% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 281,069.0000 | 49,700,000 | 1.26% | 0.01% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 191 | $254.45 | 3,539.0000 | 49,700,000 | 5.12% | 0.00% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 264 | $255.62 | 3,275.0000 | 49,700,000 | 7.46% | 0.00% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 296 | $256.17 | 2,979.0000 | 49,700,000 | 9.04% | 0.00% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1203 | $258.11 | 1,776.0000 | 49,700,000 | 40.38% | 0.00% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1373 | $259.12 | 403.0000 | 49,700,000 | 77.31% | 0.00% |
| May 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 273 | $259.80 | 130.0000 | 49,700,000 | 67.74% | 0.00% |
| April 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 288,269.0000 | 49,700,000 | 1.23% | 0.01% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 35 | $234.76 | 3,695.0000 | 49,700,000 | 0.94% | 0.00% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 278 | $236.84 | 3,417.0000 | 49,700,000 | 7.52% | 0.00% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 596 | $237.70 | 2,821.0000 | 49,700,000 | 17.44% | 0.00% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1706 | $238.56 | 1,115.0000 | 49,700,000 | 60.48% | 0.00% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 732 | $239.78 | 383.0000 | 49,700,000 | 65.65% | 0.00% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 253 | $240.55 | 130.0000 | 49,700,000 | 66.06% | 0.00% |
| April 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1000 | $234.71 | 2,730.0000 | 49,700,000 | 26.81% | 0.00% |
| April 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2349 | $235.52 | 381.0000 | 49,700,000 | 86.04% | 0.00% |
| April 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 251 | $236.37 | 130.0000 | 49,700,000 | 65.88% | 0.00% |
| April 29, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 291,869.0000 | 49,700,000 | 1.22% | 0.01% |
| April 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 341 | $236.84 | 130.0000 | 49,700,000 | 72.40% | 0.00% |
| April 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 835 | $234.36 | 2,895.0000 | 49,700,000 | 22.39% | 0.00% |
| April 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2271 | $235.23 | 624.0000 | 49,700,000 | 78.45% | 0.00% |
| April 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 417 | $236.34 | 207.0000 | 49,700,000 | 66.83% | 0.00% |
| April 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 77 | $237.00 | 130.0000 | 49,700,000 | 37.20% | 0.00% |
| April 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 299,069.0000 | 49,700,000 | 1.19% | 0.01% |
| April 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 295,469.0000 | 49,700,000 | 1.20% | 0.01% |
| April 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2056 | $235.02 | 1,674.0000 | 49,700,000 | 55.12% | 0.00% |
| April 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1203 | $236.04 | 471.0000 | 49,700,000 | 71.86% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1041 | $238.24 | 2,022.0000 | 49,700,000 | 33.99% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1217 | $239.52 | 805.0000 | 49,700,000 | 60.19% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 675 | $240.37 | 130.0000 | 49,700,000 | 83.85% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 302,669.0000 | 49,700,000 | 1.18% | 0.01% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 306,269.0000 | 49,700,000 | 1.16% | 0.01% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 536 | $235.10 | 3,194.0000 | 49,700,000 | 14.37% | 0.00% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1785 | $236.00 | 1,409.0000 | 49,700,000 | 55.89% | 0.00% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 825 | $237.04 | 584.0000 | 49,700,000 | 58.55% | 0.00% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 365 | $237.96 | 219.0000 | 49,700,000 | 62.50% | 0.00% |
| April 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 89 | $239.25 | 130.0000 | 49,700,000 | 40.64% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 36 | $233.61 | 3,694.0000 | 49,700,000 | 0.97% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 145 | $235.33 | 3,549.0000 | 49,700,000 | 3.93% | 0.00% |
| April 24, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 486 | $237.54 | 3,063.0000 | 49,700,000 | 13.69% | 0.00% |
| April 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 313,469.0000 | 49,700,000 | 1.14% | 0.01% |
| April 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 486 | $235.96 | 3,244.0000 | 49,700,000 | 13.03% | 0.00% |
| April 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2803 | $236.97 | 441.0000 | 49,700,000 | 86.41% | 0.01% |
| April 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 311 | $237.88 | 130.0000 | 49,700,000 | 70.52% | 0.00% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 266 | $234.56 | 3,464.0000 | 49,700,000 | 7.13% | 0.00% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1589 | $235.75 | 1,875.0000 | 49,700,000 | 45.87% | 0.00% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 719 | $236.76 | 1,156.0000 | 49,700,000 | 38.35% | 0.00% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 882 | $237.79 | 274.0000 | 49,700,000 | 76.30% | 0.00% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 144 | $238.36 | 130.0000 | 49,700,000 | 52.55% | 0.00% |
| April 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 309,869.0000 | 49,700,000 | 1.15% | 0.01% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 125 | $234.56 | 3,605.0000 | 49,700,000 | 3.35% | 0.00% |
| April 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 134 | $232.96 | 3,596.0000 | 49,700,000 | 3.59% | 0.00% |
| April 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 676 | $234.41 | 2,920.0000 | 49,700,000 | 18.80% | 0.00% |
| April 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1940 | $235.92 | 980.0000 | 49,700,000 | 66.44% | 0.00% |
| April 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 850 | $236.68 | 130.0000 | 49,700,000 | 86.73% | 0.00% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 397 | $236.55 | 3,208.0000 | 49,700,000 | 11.01% | 0.00% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1408 | $237.39 | 1,800.0000 | 49,700,000 | 43.89% | 0.00% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 736 | $238.36 | 1,064.0000 | 49,700,000 | 40.89% | 0.00% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 851 | $239.28 | 213.0000 | 49,700,000 | 79.98% | 0.00% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 83 | $240.16 | 130.0000 | 49,700,000 | 38.97% | 0.00% |
| April 17, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 320,669.0000 | 49,700,000 | 1.11% | 0.01% |
| April 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 317,069.0000 | 49,700,000 | 1.12% | 0.01% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 321 | $233.64 | 3,409.0000 | 49,700,000 | 8.61% | 0.00% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 884 | $234.51 | 2,525.0000 | 49,700,000 | 25.93% | 0.00% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1615 | $235.57 | 910.0000 | 49,700,000 | 63.96% | 0.00% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 625 | $236.59 | 285.0000 | 49,700,000 | 68.68% | 0.00% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 155 | $237.43 | 130.0000 | 49,700,000 | 54.39% | 0.00% |
| April 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1037 | $230.95 | 2,693.0000 | 49,700,000 | 27.80% | 0.00% |
| April 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1045 | $231.71 | 1,648.0000 | 49,700,000 | 38.80% | 0.00% |
| April 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1263 | $232.91 | 385.0000 | 49,700,000 | 76.64% | 0.00% |
| April 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 255 | $233.72 | 130.0000 | 49,700,000 | 66.23% | 0.00% |
| April 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 327,869.0000 | 49,700,000 | 1.09% | 0.01% |
| April 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 324,269.0000 | 49,700,000 | 1.10% | 0.01% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 331,469.0000 | 49,700,000 | 1.07% | 0.01% |
| April 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 3600 | $0.00 | 335,069.0000 | 49,700,000 | 1.06% | 0.01% |
| April 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1016 | $237.56 | 2,714.0000 | 49,700,000 | 27.24% | 0.00% |
| April 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1082 | $238.87 | 1,632.0000 | 49,700,000 | 39.87% | 0.00% |
| April 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1285 | $239.84 | 347.0000 | 49,700,000 | 78.74% | 0.00% |
| April 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 217 | $240.78 | 130.0000 | 49,700,000 | 62.54% | 0.00% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 3600 | $129.49 | 3,730.0000 | 49,700,000 | 2769.23% | 0.01% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 195 | $233.04 | 3,535.0000 | 49,700,000 | 5.23% | 0.00% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1114 | $234.03 | 2,421.0000 | 49,700,000 | 31.51% | 0.00% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1211 | $235.07 | 1,210.0000 | 49,700,000 | 50.02% | 0.00% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 364 | $236.03 | 846.0000 | 49,700,000 | 30.08% | 0.00% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 445 | $238.27 | 401.0000 | 49,700,000 | 52.60% | 0.00% |
| April 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 271 | $238.89 | 130.0000 | 49,700,000 | 67.58% | 0.00% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 9940 | $237.52 | 130.0000 | 49,700,000 | 98.71% | 0.02% |
| April 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 6994 | $236.74 | 8,136.0000 | 49,700,000 | 46.23% | 0.01% |
| April 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 8006 | $237.52 | 130.0000 | 49,700,000 | 98.40% | 0.02% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 13800 | $129.49 | 13,930.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 13800 | $0.00 | 338,669.0000 | 49,700,000 | 3.92% | 0.03% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 208 | $233.09 | 13,722.0000 | 49,700,000 | 1.49% | 0.00% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 102 | $234.26 | 13,620.0000 | 49,700,000 | 0.74% | 0.00% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 527 | $235.69 | 13,093.0000 | 49,700,000 | 3.87% | 0.00% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1732 | $236.73 | 11,361.0000 | 49,700,000 | 13.23% | 0.00% |
| April 10, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1291 | $237.68 | 10,070.0000 | 49,700,000 | 11.36% | 0.00% |
| April 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 352,469.0000 | 49,700,000 | 4.08% | 0.03% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 5060 | $0.00 | 367,469.0000 | 49,700,000 | 1.36% | 0.01% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 204 | $231.31 | 14,926.0000 | 49,700,000 | 1.35% | 0.00% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 562 | $232.75 | 14,364.0000 | 49,700,000 | 3.77% | 0.00% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4176 | $233.77 | 10,188.0000 | 49,700,000 | 29.07% | 0.01% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2986 | $234.74 | 7,202.0000 | 49,700,000 | 29.31% | 0.01% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4667 | $235.91 | 2,535.0000 | 49,700,000 | 64.80% | 0.01% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2405 | $236.91 | 130.0000 | 49,700,000 | 94.87% | 0.00% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 5060 | $129.49 | 5,190.0000 | 49,700,000 | 3892.31% | 0.01% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 202 | $232.43 | 4,988.0000 | 49,700,000 | 3.89% | 0.00% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 260 | $235.36 | 4,728.0000 | 49,700,000 | 5.21% | 0.00% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1639 | $236.86 | 3,089.0000 | 49,700,000 | 34.67% | 0.00% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1114 | $237.63 | 1,975.0000 | 49,700,000 | 36.06% | 0.00% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1732 | $238.85 | 243.0000 | 49,700,000 | 87.70% | 0.00% |
| April 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 113 | $239.63 | 130.0000 | 49,700,000 | 46.50% | 0.00% |
| April 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 372,529.0000 | 49,700,000 | 3.87% | 0.03% |
| April 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3181 | $230.05 | 11,226.0000 | 49,700,000 | 22.08% | 0.01% |
| April 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 8039 | $230.97 | 3,187.0000 | 49,700,000 | 71.61% | 0.02% |
| April 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3057 | $231.69 | 130.0000 | 49,700,000 | 95.92% | 0.01% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 508 | $230.65 | 14,622.0000 | 49,700,000 | 3.36% | 0.00% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1025 | $231.47 | 13,597.0000 | 49,700,000 | 7.01% | 0.00% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5323 | $232.84 | 8,274.0000 | 49,700,000 | 39.15% | 0.01% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 7478 | $233.88 | 796.0000 | 49,700,000 | 90.38% | 0.02% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 666 | $234.63 | 130.0000 | 49,700,000 | 83.67% | 0.00% |
| April 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 402,529.0000 | 49,700,000 | 3.59% | 0.03% |
| April 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 387,529.0000 | 49,700,000 | 3.73% | 0.03% |
| April 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 723 | $223.73 | 14,407.0000 | 49,700,000 | 4.78% | 0.00% |
| April 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 8121 | $229.64 | 1,607.0000 | 49,700,000 | 83.48% | 0.02% |
| April 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1477 | $230.52 | 130.0000 | 49,700,000 | 91.91% | 0.00% |
| April 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 417,529.0000 | 49,700,000 | 3.47% | 0.03% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 432,529.0000 | 49,700,000 | 3.35% | 0.03% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 489 | $223.03 | 14,641.0000 | 49,700,000 | 3.23% | 0.00% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 590 | $223.71 | 14,051.0000 | 49,700,000 | 4.03% | 0.00% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 769 | $225.17 | 13,282.0000 | 49,700,000 | 5.47% | 0.00% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1014 | $225.70 | 12,268.0000 | 49,700,000 | 7.63% | 0.00% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1373 | $227.46 | 10,895.0000 | 49,700,000 | 11.19% | 0.00% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5005 | $228.34 | 5,890.0000 | 49,700,000 | 45.94% | 0.01% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5354 | $229.38 | 536.0000 | 49,700,000 | 90.90% | 0.01% |
| April 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 406 | $230.14 | 130.0000 | 49,700,000 | 75.75% | 0.00% |
| April 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| April 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 186 | $227.02 | 14,944.0000 | 49,700,000 | 1.23% | 0.00% |
| April 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5216 | $228.81 | 9,728.0000 | 49,700,000 | 34.90% | 0.01% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2 | $246.24 | 217.0000 | 49,700,000 | 0.91% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 31 | $237.15 | 15,099.0000 | 49,700,000 | 0.20% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1418 | $238.30 | 13,681.0000 | 49,700,000 | 9.39% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1283 | $239.48 | 12,398.0000 | 49,700,000 | 9.38% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 773 | $240.38 | 11,625.0000 | 49,700,000 | 6.23% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3340 | $241.56 | 8,285.0000 | 49,700,000 | 28.73% | 0.01% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4748 | $242.38 | 3,537.0000 | 49,700,000 | 57.31% | 0.01% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2909 | $243.30 | 628.0000 | 49,700,000 | 82.24% | 0.01% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 409 | $245.49 | 219.0000 | 49,700,000 | 65.13% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 87 | $248.61 | 130.0000 | 49,700,000 | 40.09% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 14125 | $129.49 | 14,255.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1842 | $230.61 | 12,413.0000 | 49,700,000 | 12.92% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2545 | $231.74 | 9,868.0000 | 49,700,000 | 20.50% | 0.01% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1212 | $232.56 | 8,656.0000 | 49,700,000 | 12.28% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 59 | $233.83 | 8,597.0000 | 49,700,000 | 0.68% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 432 | $235.01 | 8,165.0000 | 49,700,000 | 5.03% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 102 | $236.76 | 8,063.0000 | 49,700,000 | 1.25% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 608 | $237.01 | 7,455.0000 | 49,700,000 | 7.54% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2336 | $238.54 | 5,119.0000 | 49,700,000 | 31.33% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2234 | $239.31 | 2,885.0000 | 49,700,000 | 43.64% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1565 | $240.52 | 1,320.0000 | 49,700,000 | 54.25% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1002 | $241.53 | 318.0000 | 49,700,000 | 75.91% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 21 | $242.53 | 297.0000 | 49,700,000 | 6.60% | 0.00% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 167 | $243.58 | 130.0000 | 49,700,000 | 56.23% | 0.00% |
| March 27, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 461,654.0000 | 49,700,000 | 3.15% | 0.03% |
| March 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 14125 | $0.00 | 447,529.0000 | 49,700,000 | 3.06% | 0.03% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 476,654.0000 | 49,700,000 | 3.05% | 0.03% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 468 | $239.60 | 14,662.0000 | 49,700,000 | 3.09% | 0.00% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1492 | $241.05 | 13,170.0000 | 49,700,000 | 10.18% | 0.00% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3421 | $242.12 | 9,749.0000 | 49,700,000 | 25.98% | 0.01% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4252 | $243.09 | 5,497.0000 | 49,700,000 | 43.61% | 0.01% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2924 | $243.90 | 2,573.0000 | 49,700,000 | 53.19% | 0.01% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 502 | $244.88 | 2,071.0000 | 49,700,000 | 19.51% | 0.00% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 509 | $246.57 | 1,562.0000 | 49,700,000 | 24.58% | 0.00% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 829 | $247.59 | 733.0000 | 49,700,000 | 53.07% | 0.00% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 603 | $248.49 | 130.0000 | 49,700,000 | 82.26% | 0.00% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 144 | $244.67 | 14,986.0000 | 49,700,000 | 0.95% | 0.00% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 496 | $246.46 | 14,490.0000 | 49,700,000 | 3.31% | 0.00% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5926 | $247.63 | 8,564.0000 | 49,700,000 | 40.90% | 0.01% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4366 | $248.42 | 4,198.0000 | 49,700,000 | 50.98% | 0.01% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3624 | $249.48 | 574.0000 | 49,700,000 | 86.33% | 0.01% |
| March 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 444 | $250.64 | 130.0000 | 49,700,000 | 77.35% | 0.00% |
| March 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 491,654.0000 | 49,700,000 | 2.96% | 0.03% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2497 | $237.38 | 130.0000 | 49,700,000 | 95.05% | 0.01% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1353 | $234.38 | 13,777.0000 | 49,700,000 | 8.94% | 0.00% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2500 | $235.58 | 11,277.0000 | 49,700,000 | 18.15% | 0.01% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 8650 | $236.57 | 2,627.0000 | 49,700,000 | 76.70% | 0.02% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5212 | $237.56 | 3,791.0000 | 49,700,000 | 57.89% | 0.01% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3661 | $238.29 | 130.0000 | 49,700,000 | 96.57% | 0.01% |
| March 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 521,654.0000 | 49,700,000 | 2.80% | 0.03% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 506,654.0000 | 49,700,000 | 2.88% | 0.03% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3612 | $236.62 | 9,003.0000 | 49,700,000 | 28.63% | 0.01% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1780 | $234.62 | 13,350.0000 | 49,700,000 | 11.76% | 0.00% |
| March 22, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 735 | $235.34 | 12,615.0000 | 49,700,000 | 5.51% | 0.00% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 150 | $238.28 | 130.0000 | 49,700,000 | 53.57% | 0.00% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1227 | $233.25 | 13,903.0000 | 49,700,000 | 8.11% | 0.00% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 975 | $233.98 | 12,928.0000 | 49,700,000 | 7.01% | 0.00% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2409 | $235.08 | 10,519.0000 | 49,700,000 | 18.63% | 0.00% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2958 | $236.28 | 7,561.0000 | 49,700,000 | 28.12% | 0.01% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2953 | $237.08 | 4,608.0000 | 49,700,000 | 39.06% | 0.01% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2825 | $238.48 | 1,783.0000 | 49,700,000 | 61.31% | 0.01% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 551,654.0000 | 49,700,000 | 2.65% | 0.03% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 536,654.0000 | 49,700,000 | 2.72% | 0.03% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1653 | $239.30 | 130.0000 | 49,700,000 | 92.71% | 0.00% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2290 | $234.33 | 12,840.0000 | 49,700,000 | 15.14% | 0.00% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3642 | $235.19 | 9,198.0000 | 49,700,000 | 28.36% | 0.01% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 6055 | $236.37 | 3,143.0000 | 49,700,000 | 65.83% | 0.01% |
| March 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 20, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2863 | $237.21 | 280.0000 | 49,700,000 | 91.09% | 0.01% |
| March 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4449 | $236.77 | 6,516.0000 | 49,700,000 | 40.57% | 0.01% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 566,654.0000 | 49,700,000 | 2.58% | 0.03% |
| March 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 581,654.0000 | 49,700,000 | 2.51% | 0.03% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 154 | $235.91 | 130.0000 | 49,700,000 | 54.23% | 0.00% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 6627 | $235.05 | 284.0000 | 49,700,000 | 95.89% | 0.01% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5574 | $234.31 | 6,911.0000 | 49,700,000 | 44.65% | 0.01% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1037 | $233.08 | 12,485.0000 | 49,700,000 | 7.67% | 0.00% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 659 | $232.13 | 13,522.0000 | 49,700,000 | 4.65% | 0.00% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 949 | $230.59 | 14,181.0000 | 49,700,000 | 6.27% | 0.00% |
| March 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 597 | $238.68 | 130.0000 | 49,700,000 | 82.12% | 0.00% |
| March 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5789 | $237.58 | 727.0000 | 49,700,000 | 88.84% | 0.01% |
| March 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4165 | $235.63 | 10,965.0000 | 49,700,000 | 27.53% | 0.01% |
| March 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5955 | $237.62 | 4,653.0000 | 49,700,000 | 56.14% | 0.01% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4522 | $236.74 | 10,608.0000 | 49,700,000 | 29.89% | 0.01% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 205 | $248.42 | 130.0000 | 49,700,000 | 61.19% | 0.00% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 351 | $247.19 | 335.0000 | 49,700,000 | 51.17% | 0.00% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1195 | $246.17 | 686.0000 | 49,700,000 | 63.53% | 0.00% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 192 | $244.90 | 1,881.0000 | 49,700,000 | 9.26% | 0.00% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3581 | $243.63 | 2,073.0000 | 49,700,000 | 63.34% | 0.01% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3645 | $242.60 | 5,654.0000 | 49,700,000 | 39.20% | 0.01% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3127 | $241.61 | 9,299.0000 | 49,700,000 | 25.16% | 0.01% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2704 | $240.69 | 12,426.0000 | 49,700,000 | 17.87% | 0.01% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 596,654.0000 | 49,700,000 | 2.45% | 0.03% |
| March 13, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 611,654.0000 | 49,700,000 | 2.39% | 0.03% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 158 | $241.41 | 130.0000 | 49,700,000 | 54.86% | 0.00% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1267 | $240.47 | 288.0000 | 49,700,000 | 81.48% | 0.00% |
| March 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3098 | $238.49 | 1,555.0000 | 49,700,000 | 66.58% | 0.01% |
| March 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 7091 | $247.20 | 8,039.0000 | 49,700,000 | 46.87% | 0.01% |
| March 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4580 | $249.76 | 130.0000 | 49,700,000 | 97.24% | 0.01% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2079 | $249.05 | 4,710.0000 | 49,700,000 | 30.62% | 0.00% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2404 | $247.99 | 6,789.0000 | 49,700,000 | 26.15% | 0.00% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3531 | $246.91 | 9,193.0000 | 49,700,000 | 27.75% | 0.01% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1137 | $246.05 | 12,724.0000 | 49,700,000 | 8.20% | 0.00% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1269 | $244.80 | 13,861.0000 | 49,700,000 | 8.39% | 0.00% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 626,654.0000 | 49,700,000 | 2.34% | 0.03% |
| March 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 641,654.0000 | 49,700,000 | 2.28% | 0.03% |
| March 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 772 | $249.82 | 130.0000 | 49,700,000 | 85.59% | 0.00% |
| March 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2694 | $249.15 | 902.0000 | 49,700,000 | 74.92% | 0.01% |
| March 12, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4443 | $248.09 | 3,596.0000 | 49,700,000 | 55.27% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 942 | $237.77 | 12,914.0000 | 49,700,000 | 6.80% | 0.00% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1225 | $238.75 | 13,282.0000 | 49,700,000 | 8.44% | 0.00% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 623 | $237.21 | 14,507.0000 | 49,700,000 | 4.12% | 0.00% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 95 | $243.21 | 130.0000 | 49,700,000 | 42.22% | 0.00% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1510 | $242.25 | 225.0000 | 49,700,000 | 87.03% | 0.00% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4478 | $241.30 | 1,735.0000 | 49,700,000 | 72.07% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 6223 | $240.29 | 6,213.0000 | 49,700,000 | 50.04% | 0.01% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 478 | $238.87 | 12,436.0000 | 49,700,000 | 3.70% | 0.00% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1175 | $239.56 | 12,107.0000 | 49,700,000 | 8.85% | 0.00% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1274 | $236.82 | 13,856.0000 | 49,700,000 | 8.42% | 0.00% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 656,654.0000 | 49,700,000 | 2.23% | 0.03% |
| March 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 671,654.0000 | 49,700,000 | 2.18% | 0.03% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 160 | $243.89 | 130.0000 | 49,700,000 | 55.17% | 0.00% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5139 | $243.38 | 290.0000 | 49,700,000 | 94.66% | 0.01% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5783 | $242.23 | 5,429.0000 | 49,700,000 | 51.58% | 0.01% |
| March 8, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 895 | $240.58 | 11,212.0000 | 49,700,000 | 7.39% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 559 | $233.27 | 13,246.0000 | 49,700,000 | 4.05% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1116 | $231.73 | 13,805.0000 | 49,700,000 | 7.48% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 209 | $230.28 | 14,921.0000 | 49,700,000 | 1.38% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 453 | $232.08 | 130.0000 | 49,700,000 | 77.70% | 0.00% |
| March 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2416 | $231.53 | 583.0000 | 49,700,000 | 80.56% | 0.00% |
| March 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 3431 | $230.36 | 2,999.0000 | 49,700,000 | 53.36% | 0.01% |
| March 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 6300 | $129.49 | 6,430.0000 | 49,700,000 | 4846.15% | 0.01% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 2437 | $234.57 | 10,809.0000 | 49,700,000 | 18.40% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1284 | $235.25 | 9,525.0000 | 49,700,000 | 11.88% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5219 | $236.77 | 4,306.0000 | 49,700,000 | 54.79% | 0.01% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1348 | $237.61 | 2,958.0000 | 49,700,000 | 31.31% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1871 | $239.05 | 1,087.0000 | 49,700,000 | 63.25% | 0.00% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 957 | $240.00 | 130.0000 | 49,700,000 | 88.04% | 0.00% |
| March 5, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 6300 | $0.00 | 701,654.0000 | 49,700,000 | 0.89% | 0.01% |
| March 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 686,654.0000 | 49,700,000 | 2.14% | 0.03% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1398 | $236.24 | 348.0000 | 49,700,000 | 80.07% | 0.00% |
| March 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 915 | $129.49 | 1,045.0000 | 49,700,000 | 703.85% | 0.00% |
| March 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 417 | $230.58 | 628.0000 | 49,700,000 | 39.90% | 0.00% |
| March 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 7 | $231.39 | 621.0000 | 49,700,000 | 1.11% | 0.00% |
| March 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 491 | $232.79 | 130.0000 | 49,700,000 | 79.07% | 0.00% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 15000 | $0.00 | 708,869.0000 | 49,700,000 | 2.07% | 0.03% |
| March 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Stock Options | 915 | $0.00 | 707,954.0000 | 49,700,000 | 0.13% | 0.00% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | M | Common Stock | 15000 | $129.49 | 15,130.0000 | 49,700,000 | 9999.99% | 0.03% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 1952 | $231.11 | 13,178.0000 | 49,700,000 | 12.90% | 0.00% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 5773 | $232.04 | 7,405.0000 | 49,700,000 | 43.81% | 0.01% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 4046 | $232.87 | 3,359.0000 | 49,700,000 | 54.64% | 0.01% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 987 | $234.32 | 2,372.0000 | 49,700,000 | 29.38% | 0.00% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 626 | $235.13 | 1,746.0000 | 49,700,000 | 26.39% | 0.00% |
| March 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | S | Common Stock | 218 | $237.46 | 130.0000 | 49,700,000 | 62.64% | 0.00% |